source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[cell subclass]	characteristics[activation encounter]	characteristics[activation state]	characteristics[individual]	characteristics[biological replicate]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[developmental stage]	characteristics[disease]	characteristics[depletion]	characteristics[sampling time]	assay name	Technology type	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[technical replicate]	comment[fractionation method]	comment[label]	comment[cleavage agent details]	comment[instrument]	comment[separation]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[organism part]
PXD002004-Sample-1	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_1	proteomic profiling by mass spectrometry	17Dec14_CLL_A_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_1.raw	1	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-1	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_1	proteomic profiling by mass spectrometry	17Dec14_CLL_A_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_1.raw	1	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-1	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_1	proteomic profiling by mass spectrometry	17Dec14_CLL_A_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_1.raw	1	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-1	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_1	proteomic profiling by mass spectrometry	17Dec14_CLL_A_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_1.raw	1	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-1	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_1	proteomic profiling by mass spectrometry	17Dec14_CLL_A_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_1.raw	1	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-1	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_1	proteomic profiling by mass spectrometry	17Dec14_CLL_A_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_1.raw	1	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-1	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_1	proteomic profiling by mass spectrometry	17Dec14_CLL_A_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_1.raw	1	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-1	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_1	proteomic profiling by mass spectrometry	17Dec14_CLL_A_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_1.raw	1	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-1	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_1	proteomic profiling by mass spectrometry	17Dec14_CLL_A_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_1.raw	1	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-1	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_1	proteomic profiling by mass spectrometry	17Dec14_CLL_A_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_1.raw	1	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-1	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_10	proteomic profiling by mass spectrometry	17Dec14_CLL_A_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_10.raw	2	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-2	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_10	proteomic profiling by mass spectrometry	17Dec14_CLL_A_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_10.raw	2	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-2	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_10	proteomic profiling by mass spectrometry	17Dec14_CLL_A_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_10.raw	2	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-2	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_10	proteomic profiling by mass spectrometry	17Dec14_CLL_A_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_10.raw	2	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-2	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_10	proteomic profiling by mass spectrometry	17Dec14_CLL_A_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_10.raw	2	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-2	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_10	proteomic profiling by mass spectrometry	17Dec14_CLL_A_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_10.raw	2	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-2	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_10	proteomic profiling by mass spectrometry	17Dec14_CLL_A_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_10.raw	2	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-2	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_10	proteomic profiling by mass spectrometry	17Dec14_CLL_A_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_10.raw	2	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-2	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_10	proteomic profiling by mass spectrometry	17Dec14_CLL_A_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_10.raw	2	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-2	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_10	proteomic profiling by mass spectrometry	17Dec14_CLL_A_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_10.raw	2	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-2	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_19	proteomic profiling by mass spectrometry	17Dec14_CLL_A_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_19.raw	3	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-2	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_19	proteomic profiling by mass spectrometry	17Dec14_CLL_A_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_19.raw	3	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-3	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_19	proteomic profiling by mass spectrometry	17Dec14_CLL_A_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_19.raw	3	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-3	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_19	proteomic profiling by mass spectrometry	17Dec14_CLL_A_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_19.raw	3	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-3	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_19	proteomic profiling by mass spectrometry	17Dec14_CLL_A_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_19.raw	3	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-3	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_19	proteomic profiling by mass spectrometry	17Dec14_CLL_A_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_19.raw	3	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-3	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_19	proteomic profiling by mass spectrometry	17Dec14_CLL_A_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_19.raw	3	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-3	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_19	proteomic profiling by mass spectrometry	17Dec14_CLL_A_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_19.raw	3	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-3	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_19	proteomic profiling by mass spectrometry	17Dec14_CLL_A_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_19.raw	3	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-3	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_19	proteomic profiling by mass spectrometry	17Dec14_CLL_A_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_19.raw	3	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-3	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_2	proteomic profiling by mass spectrometry	17Dec14_CLL_A_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_2.raw	4	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-3	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_2	proteomic profiling by mass spectrometry	17Dec14_CLL_A_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_2.raw	4	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-3	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_2	proteomic profiling by mass spectrometry	17Dec14_CLL_A_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_2.raw	4	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-4	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_2	proteomic profiling by mass spectrometry	17Dec14_CLL_A_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_2.raw	4	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-4	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_2	proteomic profiling by mass spectrometry	17Dec14_CLL_A_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_2.raw	4	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-4	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_2	proteomic profiling by mass spectrometry	17Dec14_CLL_A_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_2.raw	4	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-4	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_2	proteomic profiling by mass spectrometry	17Dec14_CLL_A_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_2.raw	4	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-4	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_2	proteomic profiling by mass spectrometry	17Dec14_CLL_A_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_2.raw	4	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-4	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_2	proteomic profiling by mass spectrometry	17Dec14_CLL_A_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_2.raw	4	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-4	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_2	proteomic profiling by mass spectrometry	17Dec14_CLL_A_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_2.raw	4	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-4	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_20	proteomic profiling by mass spectrometry	17Dec14_CLL_A_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_20.raw	5	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-4	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_20	proteomic profiling by mass spectrometry	17Dec14_CLL_A_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_20.raw	5	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-4	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_20	proteomic profiling by mass spectrometry	17Dec14_CLL_A_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_20.raw	5	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-4	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_20	proteomic profiling by mass spectrometry	17Dec14_CLL_A_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_20.raw	5	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-5	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_20	proteomic profiling by mass spectrometry	17Dec14_CLL_A_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_20.raw	5	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-5	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_20	proteomic profiling by mass spectrometry	17Dec14_CLL_A_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_20.raw	5	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-5	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_20	proteomic profiling by mass spectrometry	17Dec14_CLL_A_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_20.raw	5	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-5	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_20	proteomic profiling by mass spectrometry	17Dec14_CLL_A_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_20.raw	5	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-5	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_20	proteomic profiling by mass spectrometry	17Dec14_CLL_A_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_20.raw	5	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-5	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_20	proteomic profiling by mass spectrometry	17Dec14_CLL_A_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_20.raw	5	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-5	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_21	proteomic profiling by mass spectrometry	17Dec14_CLL_A_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_21.raw	6	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-5	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_21	proteomic profiling by mass spectrometry	17Dec14_CLL_A_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_21.raw	6	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-5	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_21	proteomic profiling by mass spectrometry	17Dec14_CLL_A_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_21.raw	6	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-5	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_21	proteomic profiling by mass spectrometry	17Dec14_CLL_A_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_21.raw	6	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-5	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_21	proteomic profiling by mass spectrometry	17Dec14_CLL_A_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_21.raw	6	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-6	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_21	proteomic profiling by mass spectrometry	17Dec14_CLL_A_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_21.raw	6	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-6	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_21	proteomic profiling by mass spectrometry	17Dec14_CLL_A_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_21.raw	6	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-6	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_21	proteomic profiling by mass spectrometry	17Dec14_CLL_A_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_21.raw	6	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-6	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_21	proteomic profiling by mass spectrometry	17Dec14_CLL_A_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_21.raw	6	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-6	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_21	proteomic profiling by mass spectrometry	17Dec14_CLL_A_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_21.raw	6	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-6	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_22	proteomic profiling by mass spectrometry	17Dec14_CLL_A_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_22.raw	7	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-6	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_22	proteomic profiling by mass spectrometry	17Dec14_CLL_A_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_22.raw	7	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-6	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_22	proteomic profiling by mass spectrometry	17Dec14_CLL_A_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_22.raw	7	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-6	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_22	proteomic profiling by mass spectrometry	17Dec14_CLL_A_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_22.raw	7	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-6	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_22	proteomic profiling by mass spectrometry	17Dec14_CLL_A_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_22.raw	7	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-6	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_22	proteomic profiling by mass spectrometry	17Dec14_CLL_A_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_22.raw	7	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-7	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_22	proteomic profiling by mass spectrometry	17Dec14_CLL_A_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_22.raw	7	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-7	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_22	proteomic profiling by mass spectrometry	17Dec14_CLL_A_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_22.raw	7	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-7	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_22	proteomic profiling by mass spectrometry	17Dec14_CLL_A_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_22.raw	7	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-7	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_22	proteomic profiling by mass spectrometry	17Dec14_CLL_A_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_22.raw	7	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-7	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_23	proteomic profiling by mass spectrometry	17Dec14_CLL_A_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_23.raw	8	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-7	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_23	proteomic profiling by mass spectrometry	17Dec14_CLL_A_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_23.raw	8	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-7	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_23	proteomic profiling by mass spectrometry	17Dec14_CLL_A_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_23.raw	8	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-7	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_23	proteomic profiling by mass spectrometry	17Dec14_CLL_A_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_23.raw	8	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-7	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_23	proteomic profiling by mass spectrometry	17Dec14_CLL_A_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_23.raw	8	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-7	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_23	proteomic profiling by mass spectrometry	17Dec14_CLL_A_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_23.raw	8	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-7	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_23	proteomic profiling by mass spectrometry	17Dec14_CLL_A_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_23.raw	8	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-8	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_23	proteomic profiling by mass spectrometry	17Dec14_CLL_A_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_23.raw	8	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-8	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_23	proteomic profiling by mass spectrometry	17Dec14_CLL_A_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_23.raw	8	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-8	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_23	proteomic profiling by mass spectrometry	17Dec14_CLL_A_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_23.raw	8	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-8	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_24	proteomic profiling by mass spectrometry	17Dec14_CLL_A_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_24.raw	9	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-8	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_24	proteomic profiling by mass spectrometry	17Dec14_CLL_A_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_24.raw	9	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-8	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_24	proteomic profiling by mass spectrometry	17Dec14_CLL_A_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_24.raw	9	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-8	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_24	proteomic profiling by mass spectrometry	17Dec14_CLL_A_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_24.raw	9	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-8	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_24	proteomic profiling by mass spectrometry	17Dec14_CLL_A_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_24.raw	9	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-8	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_24	proteomic profiling by mass spectrometry	17Dec14_CLL_A_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_24.raw	9	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-8	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_24	proteomic profiling by mass spectrometry	17Dec14_CLL_A_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_24.raw	9	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-8	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_24	proteomic profiling by mass spectrometry	17Dec14_CLL_A_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_24.raw	9	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-9	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_24	proteomic profiling by mass spectrometry	17Dec14_CLL_A_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_24.raw	9	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-9	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_24	proteomic profiling by mass spectrometry	17Dec14_CLL_A_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_24.raw	9	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-9	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_25	proteomic profiling by mass spectrometry	17Dec14_CLL_A_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_25.raw	10	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-9	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_25	proteomic profiling by mass spectrometry	17Dec14_CLL_A_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_25.raw	10	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-9	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_25	proteomic profiling by mass spectrometry	17Dec14_CLL_A_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_25.raw	10	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-9	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_25	proteomic profiling by mass spectrometry	17Dec14_CLL_A_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_25.raw	10	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-9	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_25	proteomic profiling by mass spectrometry	17Dec14_CLL_A_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_25.raw	10	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-9	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_25	proteomic profiling by mass spectrometry	17Dec14_CLL_A_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_25.raw	10	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-9	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_25	proteomic profiling by mass spectrometry	17Dec14_CLL_A_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_25.raw	10	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-9	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_25	proteomic profiling by mass spectrometry	17Dec14_CLL_A_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_25.raw	10	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-9	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_25	proteomic profiling by mass spectrometry	17Dec14_CLL_A_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_25.raw	10	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-10	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_25	proteomic profiling by mass spectrometry	17Dec14_CLL_A_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_25.raw	10	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-10	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_26	proteomic profiling by mass spectrometry	17Dec14_CLL_A_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_26.raw	11	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-10	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_26	proteomic profiling by mass spectrometry	17Dec14_CLL_A_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_26.raw	11	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-10	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_26	proteomic profiling by mass spectrometry	17Dec14_CLL_A_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_26.raw	11	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-10	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_26	proteomic profiling by mass spectrometry	17Dec14_CLL_A_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_26.raw	11	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-10	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_26	proteomic profiling by mass spectrometry	17Dec14_CLL_A_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_26.raw	11	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-10	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_26	proteomic profiling by mass spectrometry	17Dec14_CLL_A_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_26.raw	11	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-10	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_26	proteomic profiling by mass spectrometry	17Dec14_CLL_A_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_26.raw	11	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-10	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_26	proteomic profiling by mass spectrometry	17Dec14_CLL_A_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_26.raw	11	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-10	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_26	proteomic profiling by mass spectrometry	17Dec14_CLL_A_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_26.raw	11	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-10	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_26	proteomic profiling by mass spectrometry	17Dec14_CLL_A_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_26.raw	11	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-11	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_27	proteomic profiling by mass spectrometry	17Dec14_CLL_A_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_27.raw	12	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-11	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_27	proteomic profiling by mass spectrometry	17Dec14_CLL_A_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_27.raw	12	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-11	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_27	proteomic profiling by mass spectrometry	17Dec14_CLL_A_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_27.raw	12	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-11	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_27	proteomic profiling by mass spectrometry	17Dec14_CLL_A_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_27.raw	12	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-11	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_27	proteomic profiling by mass spectrometry	17Dec14_CLL_A_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_27.raw	12	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-11	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_27	proteomic profiling by mass spectrometry	17Dec14_CLL_A_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_27.raw	12	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-11	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_27	proteomic profiling by mass spectrometry	17Dec14_CLL_A_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_27.raw	12	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-11	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_27	proteomic profiling by mass spectrometry	17Dec14_CLL_A_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_27.raw	12	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-11	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_27	proteomic profiling by mass spectrometry	17Dec14_CLL_A_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_27.raw	12	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-11	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_27	proteomic profiling by mass spectrometry	17Dec14_CLL_A_27.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_27.raw	12	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-11	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_28	proteomic profiling by mass spectrometry	17Dec14_CLL_A_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_28.raw	13	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-12	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_28	proteomic profiling by mass spectrometry	17Dec14_CLL_A_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_28.raw	13	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-12	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_28	proteomic profiling by mass spectrometry	17Dec14_CLL_A_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_28.raw	13	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-12	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_28	proteomic profiling by mass spectrometry	17Dec14_CLL_A_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_28.raw	13	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-12	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_28	proteomic profiling by mass spectrometry	17Dec14_CLL_A_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_28.raw	13	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-12	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_28	proteomic profiling by mass spectrometry	17Dec14_CLL_A_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_28.raw	13	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-12	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_28	proteomic profiling by mass spectrometry	17Dec14_CLL_A_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_28.raw	13	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-12	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_28	proteomic profiling by mass spectrometry	17Dec14_CLL_A_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_28.raw	13	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-12	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_28	proteomic profiling by mass spectrometry	17Dec14_CLL_A_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_28.raw	13	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-12	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_28	proteomic profiling by mass spectrometry	17Dec14_CLL_A_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_28.raw	13	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-12	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_29	proteomic profiling by mass spectrometry	17Dec14_CLL_A_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_29.raw	14	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-12	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_29	proteomic profiling by mass spectrometry	17Dec14_CLL_A_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_29.raw	14	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-13	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_29	proteomic profiling by mass spectrometry	17Dec14_CLL_A_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_29.raw	14	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-13	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_29	proteomic profiling by mass spectrometry	17Dec14_CLL_A_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_29.raw	14	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-13	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_29	proteomic profiling by mass spectrometry	17Dec14_CLL_A_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_29.raw	14	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-13	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_29	proteomic profiling by mass spectrometry	17Dec14_CLL_A_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_29.raw	14	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-13	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_29	proteomic profiling by mass spectrometry	17Dec14_CLL_A_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_29.raw	14	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-13	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_29	proteomic profiling by mass spectrometry	17Dec14_CLL_A_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_29.raw	14	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-13	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_29	proteomic profiling by mass spectrometry	17Dec14_CLL_A_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_29.raw	14	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-13	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_29	proteomic profiling by mass spectrometry	17Dec14_CLL_A_29.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_29.raw	14	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-13	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_3	proteomic profiling by mass spectrometry	17Dec14_CLL_A_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_3.raw	15	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-13	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_3	proteomic profiling by mass spectrometry	17Dec14_CLL_A_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_3.raw	15	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-13	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_3	proteomic profiling by mass spectrometry	17Dec14_CLL_A_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_3.raw	15	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-14	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_3	proteomic profiling by mass spectrometry	17Dec14_CLL_A_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_3.raw	15	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-14	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_3	proteomic profiling by mass spectrometry	17Dec14_CLL_A_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_3.raw	15	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-14	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_3	proteomic profiling by mass spectrometry	17Dec14_CLL_A_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_3.raw	15	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-14	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_3	proteomic profiling by mass spectrometry	17Dec14_CLL_A_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_3.raw	15	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-14	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_3	proteomic profiling by mass spectrometry	17Dec14_CLL_A_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_3.raw	15	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-14	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_3	proteomic profiling by mass spectrometry	17Dec14_CLL_A_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_3.raw	15	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-14	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_3	proteomic profiling by mass spectrometry	17Dec14_CLL_A_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_3.raw	15	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-14	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_30	proteomic profiling by mass spectrometry	17Dec14_CLL_A_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_30.raw	16	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-14	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_30	proteomic profiling by mass spectrometry	17Dec14_CLL_A_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_30.raw	16	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-14	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_30	proteomic profiling by mass spectrometry	17Dec14_CLL_A_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_30.raw	16	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-14	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_30	proteomic profiling by mass spectrometry	17Dec14_CLL_A_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_30.raw	16	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-15	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_30	proteomic profiling by mass spectrometry	17Dec14_CLL_A_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_30.raw	16	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-15	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_30	proteomic profiling by mass spectrometry	17Dec14_CLL_A_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_30.raw	16	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-15	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_30	proteomic profiling by mass spectrometry	17Dec14_CLL_A_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_30.raw	16	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-15	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_30	proteomic profiling by mass spectrometry	17Dec14_CLL_A_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_30.raw	16	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-15	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_30	proteomic profiling by mass spectrometry	17Dec14_CLL_A_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_30.raw	16	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-15	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_30	proteomic profiling by mass spectrometry	17Dec14_CLL_A_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_30.raw	16	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-15	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_31	proteomic profiling by mass spectrometry	17Dec14_CLL_A_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_31.raw	17	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-15	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_31	proteomic profiling by mass spectrometry	17Dec14_CLL_A_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_31.raw	17	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-15	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_31	proteomic profiling by mass spectrometry	17Dec14_CLL_A_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_31.raw	17	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-15	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_31	proteomic profiling by mass spectrometry	17Dec14_CLL_A_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_31.raw	17	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-15	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_31	proteomic profiling by mass spectrometry	17Dec14_CLL_A_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_31.raw	17	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-16	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_31	proteomic profiling by mass spectrometry	17Dec14_CLL_A_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_31.raw	17	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-16	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_31	proteomic profiling by mass spectrometry	17Dec14_CLL_A_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_31.raw	17	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-16	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_31	proteomic profiling by mass spectrometry	17Dec14_CLL_A_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_31.raw	17	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-16	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_31	proteomic profiling by mass spectrometry	17Dec14_CLL_A_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_31.raw	17	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-16	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_31	proteomic profiling by mass spectrometry	17Dec14_CLL_A_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_31.raw	17	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-16	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_32	proteomic profiling by mass spectrometry	17Dec14_CLL_A_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_32.raw	18	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-16	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_32	proteomic profiling by mass spectrometry	17Dec14_CLL_A_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_32.raw	18	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-16	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_32	proteomic profiling by mass spectrometry	17Dec14_CLL_A_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_32.raw	18	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-16	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_32	proteomic profiling by mass spectrometry	17Dec14_CLL_A_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_32.raw	18	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-16	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_32	proteomic profiling by mass spectrometry	17Dec14_CLL_A_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_32.raw	18	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-16	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_32	proteomic profiling by mass spectrometry	17Dec14_CLL_A_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_32.raw	18	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-17	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_32	proteomic profiling by mass spectrometry	17Dec14_CLL_A_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_32.raw	18	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-17	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_32	proteomic profiling by mass spectrometry	17Dec14_CLL_A_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_32.raw	18	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-17	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_32	proteomic profiling by mass spectrometry	17Dec14_CLL_A_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_32.raw	18	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-17	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_32	proteomic profiling by mass spectrometry	17Dec14_CLL_A_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_32.raw	18	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-17	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_33	proteomic profiling by mass spectrometry	17Dec14_CLL_A_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_33.raw	19	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-17	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_33	proteomic profiling by mass spectrometry	17Dec14_CLL_A_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_33.raw	19	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-17	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_33	proteomic profiling by mass spectrometry	17Dec14_CLL_A_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_33.raw	19	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-17	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_33	proteomic profiling by mass spectrometry	17Dec14_CLL_A_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_33.raw	19	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-17	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_33	proteomic profiling by mass spectrometry	17Dec14_CLL_A_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_33.raw	19	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-17	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_33	proteomic profiling by mass spectrometry	17Dec14_CLL_A_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_33.raw	19	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-17	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_33	proteomic profiling by mass spectrometry	17Dec14_CLL_A_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_33.raw	19	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-18	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_33	proteomic profiling by mass spectrometry	17Dec14_CLL_A_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_33.raw	19	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-18	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_33	proteomic profiling by mass spectrometry	17Dec14_CLL_A_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_33.raw	19	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-18	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_33	proteomic profiling by mass spectrometry	17Dec14_CLL_A_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_33.raw	19	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-18	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_34	proteomic profiling by mass spectrometry	17Dec14_CLL_A_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_34.raw	20	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-18	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_34	proteomic profiling by mass spectrometry	17Dec14_CLL_A_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_34.raw	20	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-18	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_34	proteomic profiling by mass spectrometry	17Dec14_CLL_A_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_34.raw	20	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-18	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_34	proteomic profiling by mass spectrometry	17Dec14_CLL_A_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_34.raw	20	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-18	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_34	proteomic profiling by mass spectrometry	17Dec14_CLL_A_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_34.raw	20	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-18	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_34	proteomic profiling by mass spectrometry	17Dec14_CLL_A_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_34.raw	20	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-18	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_34	proteomic profiling by mass spectrometry	17Dec14_CLL_A_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_34.raw	20	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-18	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_34	proteomic profiling by mass spectrometry	17Dec14_CLL_A_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_34.raw	20	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-19	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_34	proteomic profiling by mass spectrometry	17Dec14_CLL_A_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_34.raw	20	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-19	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_34	proteomic profiling by mass spectrometry	17Dec14_CLL_A_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_34.raw	20	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-19	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_35	proteomic profiling by mass spectrometry	17Dec14_CLL_A_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_35.raw	21	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-19	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_35	proteomic profiling by mass spectrometry	17Dec14_CLL_A_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_35.raw	21	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-19	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_35	proteomic profiling by mass spectrometry	17Dec14_CLL_A_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_35.raw	21	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-19	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_35	proteomic profiling by mass spectrometry	17Dec14_CLL_A_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_35.raw	21	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-19	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_35	proteomic profiling by mass spectrometry	17Dec14_CLL_A_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_35.raw	21	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-19	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_35	proteomic profiling by mass spectrometry	17Dec14_CLL_A_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_35.raw	21	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-19	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_35	proteomic profiling by mass spectrometry	17Dec14_CLL_A_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_35.raw	21	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-19	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_35	proteomic profiling by mass spectrometry	17Dec14_CLL_A_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_35.raw	21	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-19	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_35	proteomic profiling by mass spectrometry	17Dec14_CLL_A_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_35.raw	21	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-20	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_35	proteomic profiling by mass spectrometry	17Dec14_CLL_A_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_35.raw	21	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-20	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_36	proteomic profiling by mass spectrometry	17Dec14_CLL_A_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_36.raw	22	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-20	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_36	proteomic profiling by mass spectrometry	17Dec14_CLL_A_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_36.raw	22	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-20	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_36	proteomic profiling by mass spectrometry	17Dec14_CLL_A_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_36.raw	22	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-20	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_36	proteomic profiling by mass spectrometry	17Dec14_CLL_A_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_36.raw	22	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-20	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_36	proteomic profiling by mass spectrometry	17Dec14_CLL_A_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_36.raw	22	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-20	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_36	proteomic profiling by mass spectrometry	17Dec14_CLL_A_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_36.raw	22	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-20	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_36	proteomic profiling by mass spectrometry	17Dec14_CLL_A_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_36.raw	22	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-20	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_36	proteomic profiling by mass spectrometry	17Dec14_CLL_A_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_36.raw	22	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-20	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_36	proteomic profiling by mass spectrometry	17Dec14_CLL_A_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_36.raw	22	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-20	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_36	proteomic profiling by mass spectrometry	17Dec14_CLL_A_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_36.raw	22	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-21	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_37	proteomic profiling by mass spectrometry	17Dec14_CLL_A_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_37.raw	23	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-21	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_37	proteomic profiling by mass spectrometry	17Dec14_CLL_A_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_37.raw	23	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-21	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_37	proteomic profiling by mass spectrometry	17Dec14_CLL_A_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_37.raw	23	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-21	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_37	proteomic profiling by mass spectrometry	17Dec14_CLL_A_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_37.raw	23	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-21	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_37	proteomic profiling by mass spectrometry	17Dec14_CLL_A_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_37.raw	23	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-21	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_37	proteomic profiling by mass spectrometry	17Dec14_CLL_A_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_37.raw	23	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-21	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_37	proteomic profiling by mass spectrometry	17Dec14_CLL_A_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_37.raw	23	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-21	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_37	proteomic profiling by mass spectrometry	17Dec14_CLL_A_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_37.raw	23	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-21	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_37	proteomic profiling by mass spectrometry	17Dec14_CLL_A_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_37.raw	23	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-21	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_37	proteomic profiling by mass spectrometry	17Dec14_CLL_A_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_37.raw	23	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-21	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_38	proteomic profiling by mass spectrometry	17Dec14_CLL_A_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_38.raw	24	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-22	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_38	proteomic profiling by mass spectrometry	17Dec14_CLL_A_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_38.raw	24	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-22	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_38	proteomic profiling by mass spectrometry	17Dec14_CLL_A_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_38.raw	24	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-22	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_38	proteomic profiling by mass spectrometry	17Dec14_CLL_A_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_38.raw	24	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-22	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_38	proteomic profiling by mass spectrometry	17Dec14_CLL_A_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_38.raw	24	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-22	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_38	proteomic profiling by mass spectrometry	17Dec14_CLL_A_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_38.raw	24	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-22	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_38	proteomic profiling by mass spectrometry	17Dec14_CLL_A_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_38.raw	24	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-22	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_38	proteomic profiling by mass spectrometry	17Dec14_CLL_A_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_38.raw	24	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-22	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_38	proteomic profiling by mass spectrometry	17Dec14_CLL_A_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_38.raw	24	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-22	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_38	proteomic profiling by mass spectrometry	17Dec14_CLL_A_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_38.raw	24	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-22	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_39	proteomic profiling by mass spectrometry	17Dec14_CLL_A_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_39.raw	25	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-22	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_39	proteomic profiling by mass spectrometry	17Dec14_CLL_A_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_39.raw	25	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-23	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_39	proteomic profiling by mass spectrometry	17Dec14_CLL_A_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_39.raw	25	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-23	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_39	proteomic profiling by mass spectrometry	17Dec14_CLL_A_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_39.raw	25	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-23	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_39	proteomic profiling by mass spectrometry	17Dec14_CLL_A_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_39.raw	25	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-23	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_39	proteomic profiling by mass spectrometry	17Dec14_CLL_A_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_39.raw	25	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-23	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_39	proteomic profiling by mass spectrometry	17Dec14_CLL_A_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_39.raw	25	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-23	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_39	proteomic profiling by mass spectrometry	17Dec14_CLL_A_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_39.raw	25	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-23	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_39	proteomic profiling by mass spectrometry	17Dec14_CLL_A_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_39.raw	25	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-23	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_39	proteomic profiling by mass spectrometry	17Dec14_CLL_A_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_39.raw	25	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-23	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_4	proteomic profiling by mass spectrometry	17Dec14_CLL_A_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_4.raw	26	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-23	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_4	proteomic profiling by mass spectrometry	17Dec14_CLL_A_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_4.raw	26	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-23	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_4	proteomic profiling by mass spectrometry	17Dec14_CLL_A_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_4.raw	26	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-24	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_4	proteomic profiling by mass spectrometry	17Dec14_CLL_A_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_4.raw	26	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-24	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_4	proteomic profiling by mass spectrometry	17Dec14_CLL_A_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_4.raw	26	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-24	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_4	proteomic profiling by mass spectrometry	17Dec14_CLL_A_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_4.raw	26	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-24	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_4	proteomic profiling by mass spectrometry	17Dec14_CLL_A_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_4.raw	26	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-24	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_4	proteomic profiling by mass spectrometry	17Dec14_CLL_A_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_4.raw	26	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-24	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_4	proteomic profiling by mass spectrometry	17Dec14_CLL_A_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_4.raw	26	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-24	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_4	proteomic profiling by mass spectrometry	17Dec14_CLL_A_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_4.raw	26	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-24	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_40	proteomic profiling by mass spectrometry	17Dec14_CLL_A_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_40.raw	27	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-24	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_40	proteomic profiling by mass spectrometry	17Dec14_CLL_A_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_40.raw	27	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-24	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_40	proteomic profiling by mass spectrometry	17Dec14_CLL_A_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_40.raw	27	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-24	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_40	proteomic profiling by mass spectrometry	17Dec14_CLL_A_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_40.raw	27	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-25	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_40	proteomic profiling by mass spectrometry	17Dec14_CLL_A_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_40.raw	27	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-25	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_40	proteomic profiling by mass spectrometry	17Dec14_CLL_A_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_40.raw	27	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-25	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_40	proteomic profiling by mass spectrometry	17Dec14_CLL_A_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_40.raw	27	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-25	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_40	proteomic profiling by mass spectrometry	17Dec14_CLL_A_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_40.raw	27	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-25	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_40	proteomic profiling by mass spectrometry	17Dec14_CLL_A_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_40.raw	27	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-25	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_40	proteomic profiling by mass spectrometry	17Dec14_CLL_A_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_40.raw	27	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-25	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_41	proteomic profiling by mass spectrometry	17Dec14_CLL_A_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_41.raw	28	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-25	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_41	proteomic profiling by mass spectrometry	17Dec14_CLL_A_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_41.raw	28	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-25	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_41	proteomic profiling by mass spectrometry	17Dec14_CLL_A_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_41.raw	28	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-25	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_41	proteomic profiling by mass spectrometry	17Dec14_CLL_A_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_41.raw	28	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-25	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_41	proteomic profiling by mass spectrometry	17Dec14_CLL_A_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_41.raw	28	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-26	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_41	proteomic profiling by mass spectrometry	17Dec14_CLL_A_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_41.raw	28	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-26	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_41	proteomic profiling by mass spectrometry	17Dec14_CLL_A_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_41.raw	28	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-26	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_41	proteomic profiling by mass spectrometry	17Dec14_CLL_A_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_41.raw	28	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-26	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_41	proteomic profiling by mass spectrometry	17Dec14_CLL_A_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_41.raw	28	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-26	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_41	proteomic profiling by mass spectrometry	17Dec14_CLL_A_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_41.raw	28	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-26	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_42	proteomic profiling by mass spectrometry	17Dec14_CLL_A_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_42.raw	29	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-26	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_42	proteomic profiling by mass spectrometry	17Dec14_CLL_A_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_42.raw	29	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-26	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_42	proteomic profiling by mass spectrometry	17Dec14_CLL_A_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_42.raw	29	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-26	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_42	proteomic profiling by mass spectrometry	17Dec14_CLL_A_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_42.raw	29	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-26	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_42	proteomic profiling by mass spectrometry	17Dec14_CLL_A_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_42.raw	29	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-26	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_42	proteomic profiling by mass spectrometry	17Dec14_CLL_A_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_42.raw	29	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-27	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_42	proteomic profiling by mass spectrometry	17Dec14_CLL_A_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_42.raw	29	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-27	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_42	proteomic profiling by mass spectrometry	17Dec14_CLL_A_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_42.raw	29	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-27	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_42	proteomic profiling by mass spectrometry	17Dec14_CLL_A_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_42.raw	29	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-27	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_42	proteomic profiling by mass spectrometry	17Dec14_CLL_A_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_42.raw	29	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-27	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_43	proteomic profiling by mass spectrometry	17Dec14_CLL_A_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_43.raw	30	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-27	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_43	proteomic profiling by mass spectrometry	17Dec14_CLL_A_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_43.raw	30	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-27	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_43	proteomic profiling by mass spectrometry	17Dec14_CLL_A_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_43.raw	30	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-27	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_43	proteomic profiling by mass spectrometry	17Dec14_CLL_A_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_43.raw	30	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-27	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_43	proteomic profiling by mass spectrometry	17Dec14_CLL_A_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_43.raw	30	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-27	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_43	proteomic profiling by mass spectrometry	17Dec14_CLL_A_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_43.raw	30	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-27	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_43	proteomic profiling by mass spectrometry	17Dec14_CLL_A_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_43.raw	30	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-28	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_43	proteomic profiling by mass spectrometry	17Dec14_CLL_A_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_43.raw	30	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-28	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_43	proteomic profiling by mass spectrometry	17Dec14_CLL_A_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_43.raw	30	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-28	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_43	proteomic profiling by mass spectrometry	17Dec14_CLL_A_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_43.raw	30	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-28	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_44	proteomic profiling by mass spectrometry	17Dec14_CLL_A_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_44.raw	31	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-28	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_44	proteomic profiling by mass spectrometry	17Dec14_CLL_A_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_44.raw	31	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-28	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_44	proteomic profiling by mass spectrometry	17Dec14_CLL_A_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_44.raw	31	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-28	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_44	proteomic profiling by mass spectrometry	17Dec14_CLL_A_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_44.raw	31	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-28	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_44	proteomic profiling by mass spectrometry	17Dec14_CLL_A_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_44.raw	31	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-28	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_44	proteomic profiling by mass spectrometry	17Dec14_CLL_A_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_44.raw	31	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-28	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_44	proteomic profiling by mass spectrometry	17Dec14_CLL_A_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_44.raw	31	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-28	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_44	proteomic profiling by mass spectrometry	17Dec14_CLL_A_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_44.raw	31	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-29	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_44	proteomic profiling by mass spectrometry	17Dec14_CLL_A_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_44.raw	31	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-29	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_44	proteomic profiling by mass spectrometry	17Dec14_CLL_A_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_44.raw	31	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-29	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_45	proteomic profiling by mass spectrometry	17Dec14_CLL_A_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_45.raw	32	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-29	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_45	proteomic profiling by mass spectrometry	17Dec14_CLL_A_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_45.raw	32	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-29	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_45	proteomic profiling by mass spectrometry	17Dec14_CLL_A_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_45.raw	32	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-29	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_45	proteomic profiling by mass spectrometry	17Dec14_CLL_A_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_45.raw	32	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-29	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_45	proteomic profiling by mass spectrometry	17Dec14_CLL_A_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_45.raw	32	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-29	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_45	proteomic profiling by mass spectrometry	17Dec14_CLL_A_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_45.raw	32	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-29	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_45	proteomic profiling by mass spectrometry	17Dec14_CLL_A_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_45.raw	32	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-29	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_45	proteomic profiling by mass spectrometry	17Dec14_CLL_A_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_45.raw	32	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-29	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_45	proteomic profiling by mass spectrometry	17Dec14_CLL_A_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_45.raw	32	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-30	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_45	proteomic profiling by mass spectrometry	17Dec14_CLL_A_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_45.raw	32	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-30	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_46	proteomic profiling by mass spectrometry	17Dec14_CLL_A_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_46.raw	33	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-30	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_46	proteomic profiling by mass spectrometry	17Dec14_CLL_A_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_46.raw	33	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-30	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_46	proteomic profiling by mass spectrometry	17Dec14_CLL_A_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_46.raw	33	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-30	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_46	proteomic profiling by mass spectrometry	17Dec14_CLL_A_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_46.raw	33	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-30	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_46	proteomic profiling by mass spectrometry	17Dec14_CLL_A_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_46.raw	33	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-30	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_46	proteomic profiling by mass spectrometry	17Dec14_CLL_A_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_46.raw	33	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-30	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_46	proteomic profiling by mass spectrometry	17Dec14_CLL_A_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_46.raw	33	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-30	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_46	proteomic profiling by mass spectrometry	17Dec14_CLL_A_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_46.raw	33	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-30	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_46	proteomic profiling by mass spectrometry	17Dec14_CLL_A_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_46.raw	33	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-30	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_46	proteomic profiling by mass spectrometry	17Dec14_CLL_A_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_46.raw	33	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-31	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_47	proteomic profiling by mass spectrometry	17Dec14_CLL_A_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_47.raw	34	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-31	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_47	proteomic profiling by mass spectrometry	17Dec14_CLL_A_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_47.raw	34	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-31	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_47	proteomic profiling by mass spectrometry	17Dec14_CLL_A_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_47.raw	34	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-31	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_47	proteomic profiling by mass spectrometry	17Dec14_CLL_A_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_47.raw	34	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-31	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_47	proteomic profiling by mass spectrometry	17Dec14_CLL_A_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_47.raw	34	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-31	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_47	proteomic profiling by mass spectrometry	17Dec14_CLL_A_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_47.raw	34	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-31	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_47	proteomic profiling by mass spectrometry	17Dec14_CLL_A_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_47.raw	34	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-31	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_47	proteomic profiling by mass spectrometry	17Dec14_CLL_A_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_47.raw	34	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-31	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_47	proteomic profiling by mass spectrometry	17Dec14_CLL_A_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_47.raw	34	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-31	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_47	proteomic profiling by mass spectrometry	17Dec14_CLL_A_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_47.raw	34	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-31	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_48	proteomic profiling by mass spectrometry	17Dec14_CLL_A_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_48.raw	35	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-32	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_48	proteomic profiling by mass spectrometry	17Dec14_CLL_A_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_48.raw	35	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-32	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_48	proteomic profiling by mass spectrometry	17Dec14_CLL_A_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_48.raw	35	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-32	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_48	proteomic profiling by mass spectrometry	17Dec14_CLL_A_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_48.raw	35	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-32	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_48	proteomic profiling by mass spectrometry	17Dec14_CLL_A_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_48.raw	35	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-32	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_48	proteomic profiling by mass spectrometry	17Dec14_CLL_A_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_48.raw	35	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-32	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_48	proteomic profiling by mass spectrometry	17Dec14_CLL_A_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_48.raw	35	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-32	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_48	proteomic profiling by mass spectrometry	17Dec14_CLL_A_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_48.raw	35	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-32	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_48	proteomic profiling by mass spectrometry	17Dec14_CLL_A_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_48.raw	35	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-32	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_48	proteomic profiling by mass spectrometry	17Dec14_CLL_A_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_48.raw	35	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-32	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_49	proteomic profiling by mass spectrometry	17Dec14_CLL_A_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_49.raw	36	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-32	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_49	proteomic profiling by mass spectrometry	17Dec14_CLL_A_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_49.raw	36	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-33	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_49	proteomic profiling by mass spectrometry	17Dec14_CLL_A_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_49.raw	36	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-33	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_49	proteomic profiling by mass spectrometry	17Dec14_CLL_A_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_49.raw	36	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-33	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_49	proteomic profiling by mass spectrometry	17Dec14_CLL_A_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_49.raw	36	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-33	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_49	proteomic profiling by mass spectrometry	17Dec14_CLL_A_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_49.raw	36	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-33	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_49	proteomic profiling by mass spectrometry	17Dec14_CLL_A_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_49.raw	36	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-33	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_49	proteomic profiling by mass spectrometry	17Dec14_CLL_A_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_49.raw	36	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-33	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_49	proteomic profiling by mass spectrometry	17Dec14_CLL_A_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_49.raw	36	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-33	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_49	proteomic profiling by mass spectrometry	17Dec14_CLL_A_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_49.raw	36	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-33	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_5	proteomic profiling by mass spectrometry	17Dec14_CLL_A_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_5.raw	37	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-33	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_5	proteomic profiling by mass spectrometry	17Dec14_CLL_A_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_5.raw	37	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-33	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_5	proteomic profiling by mass spectrometry	17Dec14_CLL_A_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_5.raw	37	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-34	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_5	proteomic profiling by mass spectrometry	17Dec14_CLL_A_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_5.raw	37	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-34	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_5	proteomic profiling by mass spectrometry	17Dec14_CLL_A_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_5.raw	37	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-34	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_5	proteomic profiling by mass spectrometry	17Dec14_CLL_A_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_5.raw	37	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-34	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_5	proteomic profiling by mass spectrometry	17Dec14_CLL_A_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_5.raw	37	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-34	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_5	proteomic profiling by mass spectrometry	17Dec14_CLL_A_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_5.raw	37	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-34	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_5	proteomic profiling by mass spectrometry	17Dec14_CLL_A_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_5.raw	37	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-34	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_5	proteomic profiling by mass spectrometry	17Dec14_CLL_A_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_5.raw	37	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-34	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_50	proteomic profiling by mass spectrometry	17Dec14_CLL_A_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_50.raw	38	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-34	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_50	proteomic profiling by mass spectrometry	17Dec14_CLL_A_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_50.raw	38	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-34	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_50	proteomic profiling by mass spectrometry	17Dec14_CLL_A_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_50.raw	38	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-34	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_50	proteomic profiling by mass spectrometry	17Dec14_CLL_A_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_50.raw	38	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-35	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_50	proteomic profiling by mass spectrometry	17Dec14_CLL_A_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_50.raw	38	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-35	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_50	proteomic profiling by mass spectrometry	17Dec14_CLL_A_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_50.raw	38	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-35	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_50	proteomic profiling by mass spectrometry	17Dec14_CLL_A_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_50.raw	38	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-35	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_50	proteomic profiling by mass spectrometry	17Dec14_CLL_A_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_50.raw	38	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-35	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_50	proteomic profiling by mass spectrometry	17Dec14_CLL_A_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_50.raw	38	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-35	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_50	proteomic profiling by mass spectrometry	17Dec14_CLL_A_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_50.raw	38	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-35	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_51	proteomic profiling by mass spectrometry	17Dec14_CLL_A_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_51.raw	39	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-35	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_51	proteomic profiling by mass spectrometry	17Dec14_CLL_A_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_51.raw	39	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-35	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_51	proteomic profiling by mass spectrometry	17Dec14_CLL_A_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_51.raw	39	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-35	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_51	proteomic profiling by mass spectrometry	17Dec14_CLL_A_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_51.raw	39	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-35	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_51	proteomic profiling by mass spectrometry	17Dec14_CLL_A_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_51.raw	39	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-36	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_51	proteomic profiling by mass spectrometry	17Dec14_CLL_A_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_51.raw	39	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-36	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_51	proteomic profiling by mass spectrometry	17Dec14_CLL_A_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_51.raw	39	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-36	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_51	proteomic profiling by mass spectrometry	17Dec14_CLL_A_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_51.raw	39	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-36	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_51	proteomic profiling by mass spectrometry	17Dec14_CLL_A_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_51.raw	39	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-36	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_51	proteomic profiling by mass spectrometry	17Dec14_CLL_A_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_51.raw	39	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-36	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_52	proteomic profiling by mass spectrometry	17Dec14_CLL_A_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_52.raw	40	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-36	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_52	proteomic profiling by mass spectrometry	17Dec14_CLL_A_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_52.raw	40	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-36	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_52	proteomic profiling by mass spectrometry	17Dec14_CLL_A_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_52.raw	40	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-36	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_52	proteomic profiling by mass spectrometry	17Dec14_CLL_A_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_52.raw	40	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-36	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_52	proteomic profiling by mass spectrometry	17Dec14_CLL_A_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_52.raw	40	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-36	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_52	proteomic profiling by mass spectrometry	17Dec14_CLL_A_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_52.raw	40	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-37	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_52	proteomic profiling by mass spectrometry	17Dec14_CLL_A_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_52.raw	40	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-37	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_52	proteomic profiling by mass spectrometry	17Dec14_CLL_A_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_52.raw	40	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-37	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_52	proteomic profiling by mass spectrometry	17Dec14_CLL_A_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_52.raw	40	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-37	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_52	proteomic profiling by mass spectrometry	17Dec14_CLL_A_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_52.raw	40	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-37	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_53	proteomic profiling by mass spectrometry	17Dec14_CLL_A_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_53.raw	41	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-37	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_53	proteomic profiling by mass spectrometry	17Dec14_CLL_A_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_53.raw	41	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-37	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_53	proteomic profiling by mass spectrometry	17Dec14_CLL_A_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_53.raw	41	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-37	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_53	proteomic profiling by mass spectrometry	17Dec14_CLL_A_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_53.raw	41	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-37	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_53	proteomic profiling by mass spectrometry	17Dec14_CLL_A_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_53.raw	41	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-37	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_53	proteomic profiling by mass spectrometry	17Dec14_CLL_A_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_53.raw	41	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-37	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_53	proteomic profiling by mass spectrometry	17Dec14_CLL_A_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_53.raw	41	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-38	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_53	proteomic profiling by mass spectrometry	17Dec14_CLL_A_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_53.raw	41	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-38	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_53	proteomic profiling by mass spectrometry	17Dec14_CLL_A_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_53.raw	41	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-38	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_53	proteomic profiling by mass spectrometry	17Dec14_CLL_A_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_53.raw	41	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-38	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_54	proteomic profiling by mass spectrometry	17Dec14_CLL_A_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_54.raw	42	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-38	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_54	proteomic profiling by mass spectrometry	17Dec14_CLL_A_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_54.raw	42	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-38	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_54	proteomic profiling by mass spectrometry	17Dec14_CLL_A_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_54.raw	42	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-38	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_54	proteomic profiling by mass spectrometry	17Dec14_CLL_A_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_54.raw	42	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-38	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_54	proteomic profiling by mass spectrometry	17Dec14_CLL_A_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_54.raw	42	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-38	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_54	proteomic profiling by mass spectrometry	17Dec14_CLL_A_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_54.raw	42	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-38	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_54	proteomic profiling by mass spectrometry	17Dec14_CLL_A_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_54.raw	42	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-38	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_54	proteomic profiling by mass spectrometry	17Dec14_CLL_A_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_54.raw	42	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-39	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_54	proteomic profiling by mass spectrometry	17Dec14_CLL_A_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_54.raw	42	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-39	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_54	proteomic profiling by mass spectrometry	17Dec14_CLL_A_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_54.raw	42	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-39	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_55	proteomic profiling by mass spectrometry	17Dec14_CLL_A_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_55.raw	43	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-39	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_55	proteomic profiling by mass spectrometry	17Dec14_CLL_A_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_55.raw	43	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-39	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_55	proteomic profiling by mass spectrometry	17Dec14_CLL_A_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_55.raw	43	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-39	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_55	proteomic profiling by mass spectrometry	17Dec14_CLL_A_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_55.raw	43	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-39	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_55	proteomic profiling by mass spectrometry	17Dec14_CLL_A_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_55.raw	43	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-39	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_55	proteomic profiling by mass spectrometry	17Dec14_CLL_A_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_55.raw	43	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-39	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_55	proteomic profiling by mass spectrometry	17Dec14_CLL_A_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_55.raw	43	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-39	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_55	proteomic profiling by mass spectrometry	17Dec14_CLL_A_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_55.raw	43	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-39	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_55	proteomic profiling by mass spectrometry	17Dec14_CLL_A_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_55.raw	43	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-40	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_55	proteomic profiling by mass spectrometry	17Dec14_CLL_A_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_55.raw	43	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-40	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_56	proteomic profiling by mass spectrometry	17Dec14_CLL_A_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_56.raw	44	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-40	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_56	proteomic profiling by mass spectrometry	17Dec14_CLL_A_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_56.raw	44	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-40	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_56	proteomic profiling by mass spectrometry	17Dec14_CLL_A_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_56.raw	44	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-40	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_56	proteomic profiling by mass spectrometry	17Dec14_CLL_A_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_56.raw	44	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-40	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_56	proteomic profiling by mass spectrometry	17Dec14_CLL_A_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_56.raw	44	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-40	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_56	proteomic profiling by mass spectrometry	17Dec14_CLL_A_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_56.raw	44	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-40	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_56	proteomic profiling by mass spectrometry	17Dec14_CLL_A_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_56.raw	44	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-40	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_56	proteomic profiling by mass spectrometry	17Dec14_CLL_A_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_56.raw	44	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-40	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_56	proteomic profiling by mass spectrometry	17Dec14_CLL_A_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_56.raw	44	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-40	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_56	proteomic profiling by mass spectrometry	17Dec14_CLL_A_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_56.raw	44	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-41	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_57	proteomic profiling by mass spectrometry	17Dec14_CLL_A_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_57.raw	45	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-41	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_57	proteomic profiling by mass spectrometry	17Dec14_CLL_A_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_57.raw	45	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-41	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_57	proteomic profiling by mass spectrometry	17Dec14_CLL_A_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_57.raw	45	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-41	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_57	proteomic profiling by mass spectrometry	17Dec14_CLL_A_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_57.raw	45	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-41	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_57	proteomic profiling by mass spectrometry	17Dec14_CLL_A_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_57.raw	45	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-41	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_57	proteomic profiling by mass spectrometry	17Dec14_CLL_A_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_57.raw	45	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-41	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_57	proteomic profiling by mass spectrometry	17Dec14_CLL_A_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_57.raw	45	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-41	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_57	proteomic profiling by mass spectrometry	17Dec14_CLL_A_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_57.raw	45	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-41	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_57	proteomic profiling by mass spectrometry	17Dec14_CLL_A_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_57.raw	45	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-41	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_57	proteomic profiling by mass spectrometry	17Dec14_CLL_A_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_57.raw	45	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-41	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_58	proteomic profiling by mass spectrometry	17Dec14_CLL_A_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_58.raw	46	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-42	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_58	proteomic profiling by mass spectrometry	17Dec14_CLL_A_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_58.raw	46	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-42	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_58	proteomic profiling by mass spectrometry	17Dec14_CLL_A_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_58.raw	46	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-42	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_58	proteomic profiling by mass spectrometry	17Dec14_CLL_A_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_58.raw	46	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-42	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_58	proteomic profiling by mass spectrometry	17Dec14_CLL_A_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_58.raw	46	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-42	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_58	proteomic profiling by mass spectrometry	17Dec14_CLL_A_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_58.raw	46	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-42	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_58	proteomic profiling by mass spectrometry	17Dec14_CLL_A_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_58.raw	46	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-42	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_58	proteomic profiling by mass spectrometry	17Dec14_CLL_A_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_58.raw	46	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-42	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_58	proteomic profiling by mass spectrometry	17Dec14_CLL_A_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_58.raw	46	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-42	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_58	proteomic profiling by mass spectrometry	17Dec14_CLL_A_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_58.raw	46	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-42	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_59	proteomic profiling by mass spectrometry	17Dec14_CLL_A_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_59.raw	47	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-42	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_59	proteomic profiling by mass spectrometry	17Dec14_CLL_A_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_59.raw	47	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-43	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_59	proteomic profiling by mass spectrometry	17Dec14_CLL_A_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_59.raw	47	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-43	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_59	proteomic profiling by mass spectrometry	17Dec14_CLL_A_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_59.raw	47	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-43	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_59	proteomic profiling by mass spectrometry	17Dec14_CLL_A_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_59.raw	47	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-43	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_59	proteomic profiling by mass spectrometry	17Dec14_CLL_A_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_59.raw	47	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-43	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_59	proteomic profiling by mass spectrometry	17Dec14_CLL_A_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_59.raw	47	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-43	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_59	proteomic profiling by mass spectrometry	17Dec14_CLL_A_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_59.raw	47	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-43	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_59	proteomic profiling by mass spectrometry	17Dec14_CLL_A_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_59.raw	47	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-43	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_59	proteomic profiling by mass spectrometry	17Dec14_CLL_A_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_59.raw	47	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-43	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_6	proteomic profiling by mass spectrometry	17Dec14_CLL_A_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_6.raw	48	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-43	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_6	proteomic profiling by mass spectrometry	17Dec14_CLL_A_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_6.raw	48	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-43	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_6	proteomic profiling by mass spectrometry	17Dec14_CLL_A_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_6.raw	48	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-44	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_6	proteomic profiling by mass spectrometry	17Dec14_CLL_A_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_6.raw	48	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-44	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_6	proteomic profiling by mass spectrometry	17Dec14_CLL_A_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_6.raw	48	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-44	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_6	proteomic profiling by mass spectrometry	17Dec14_CLL_A_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_6.raw	48	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-44	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_6	proteomic profiling by mass spectrometry	17Dec14_CLL_A_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_6.raw	48	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-44	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_6	proteomic profiling by mass spectrometry	17Dec14_CLL_A_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_6.raw	48	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-44	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_6	proteomic profiling by mass spectrometry	17Dec14_CLL_A_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_6.raw	48	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-44	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_6	proteomic profiling by mass spectrometry	17Dec14_CLL_A_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_6.raw	48	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-44	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_60	proteomic profiling by mass spectrometry	17Dec14_CLL_A_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_60.raw	49	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-44	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_60	proteomic profiling by mass spectrometry	17Dec14_CLL_A_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_60.raw	49	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-44	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_60	proteomic profiling by mass spectrometry	17Dec14_CLL_A_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_60.raw	49	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-44	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_60	proteomic profiling by mass spectrometry	17Dec14_CLL_A_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_60.raw	49	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-45	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_60	proteomic profiling by mass spectrometry	17Dec14_CLL_A_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_60.raw	49	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-45	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_60	proteomic profiling by mass spectrometry	17Dec14_CLL_A_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_60.raw	49	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-45	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_60	proteomic profiling by mass spectrometry	17Dec14_CLL_A_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_60.raw	49	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-45	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_60	proteomic profiling by mass spectrometry	17Dec14_CLL_A_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_60.raw	49	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-45	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_60	proteomic profiling by mass spectrometry	17Dec14_CLL_A_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_60.raw	49	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-45	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_60	proteomic profiling by mass spectrometry	17Dec14_CLL_A_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_60.raw	49	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-45	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_61	proteomic profiling by mass spectrometry	17Dec14_CLL_A_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_61.raw	50	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-45	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_61	proteomic profiling by mass spectrometry	17Dec14_CLL_A_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_61.raw	50	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-45	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_61	proteomic profiling by mass spectrometry	17Dec14_CLL_A_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_61.raw	50	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-45	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_61	proteomic profiling by mass spectrometry	17Dec14_CLL_A_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_61.raw	50	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-45	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_61	proteomic profiling by mass spectrometry	17Dec14_CLL_A_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_61.raw	50	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-46	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_61	proteomic profiling by mass spectrometry	17Dec14_CLL_A_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_61.raw	50	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-46	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_61	proteomic profiling by mass spectrometry	17Dec14_CLL_A_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_61.raw	50	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-46	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_61	proteomic profiling by mass spectrometry	17Dec14_CLL_A_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_61.raw	50	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-46	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_61	proteomic profiling by mass spectrometry	17Dec14_CLL_A_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_61.raw	50	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-46	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_61	proteomic profiling by mass spectrometry	17Dec14_CLL_A_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_61.raw	50	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-46	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_62	proteomic profiling by mass spectrometry	17Dec14_CLL_A_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_62.raw	51	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-46	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_62	proteomic profiling by mass spectrometry	17Dec14_CLL_A_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_62.raw	51	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-46	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_62	proteomic profiling by mass spectrometry	17Dec14_CLL_A_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_62.raw	51	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-46	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_62	proteomic profiling by mass spectrometry	17Dec14_CLL_A_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_62.raw	51	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-46	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_62	proteomic profiling by mass spectrometry	17Dec14_CLL_A_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_62.raw	51	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-46	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_62	proteomic profiling by mass spectrometry	17Dec14_CLL_A_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_62.raw	51	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-47	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_62	proteomic profiling by mass spectrometry	17Dec14_CLL_A_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_62.raw	51	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-47	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_62	proteomic profiling by mass spectrometry	17Dec14_CLL_A_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_62.raw	51	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-47	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_62	proteomic profiling by mass spectrometry	17Dec14_CLL_A_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_62.raw	51	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-47	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_62	proteomic profiling by mass spectrometry	17Dec14_CLL_A_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_62.raw	51	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-47	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_63	proteomic profiling by mass spectrometry	17Dec14_CLL_A_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_63.raw	52	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-47	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_63	proteomic profiling by mass spectrometry	17Dec14_CLL_A_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_63.raw	52	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-47	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_63	proteomic profiling by mass spectrometry	17Dec14_CLL_A_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_63.raw	52	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-47	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_63	proteomic profiling by mass spectrometry	17Dec14_CLL_A_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_63.raw	52	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-47	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_63	proteomic profiling by mass spectrometry	17Dec14_CLL_A_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_63.raw	52	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-47	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_63	proteomic profiling by mass spectrometry	17Dec14_CLL_A_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_63.raw	52	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-47	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_63	proteomic profiling by mass spectrometry	17Dec14_CLL_A_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_63.raw	52	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-48	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_63	proteomic profiling by mass spectrometry	17Dec14_CLL_A_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_63.raw	52	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-48	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_63	proteomic profiling by mass spectrometry	17Dec14_CLL_A_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_63.raw	52	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-48	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_63	proteomic profiling by mass spectrometry	17Dec14_CLL_A_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_63.raw	52	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-48	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_7	proteomic profiling by mass spectrometry	17Dec14_CLL_A_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_7.raw	53	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-48	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_7	proteomic profiling by mass spectrometry	17Dec14_CLL_A_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_7.raw	53	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-48	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_7	proteomic profiling by mass spectrometry	17Dec14_CLL_A_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_7.raw	53	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-48	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_7	proteomic profiling by mass spectrometry	17Dec14_CLL_A_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_7.raw	53	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-48	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_7	proteomic profiling by mass spectrometry	17Dec14_CLL_A_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_7.raw	53	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-48	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_7	proteomic profiling by mass spectrometry	17Dec14_CLL_A_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_7.raw	53	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-48	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_7	proteomic profiling by mass spectrometry	17Dec14_CLL_A_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_7.raw	53	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-48	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_7	proteomic profiling by mass spectrometry	17Dec14_CLL_A_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_7.raw	53	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-49	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_7	proteomic profiling by mass spectrometry	17Dec14_CLL_A_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_7.raw	53	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-49	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_7	proteomic profiling by mass spectrometry	17Dec14_CLL_A_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_7.raw	53	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-49	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_8	proteomic profiling by mass spectrometry	17Dec14_CLL_A_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_8.raw	54	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-49	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_8	proteomic profiling by mass spectrometry	17Dec14_CLL_A_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_8.raw	54	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-49	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_8	proteomic profiling by mass spectrometry	17Dec14_CLL_A_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_8.raw	54	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-49	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_8	proteomic profiling by mass spectrometry	17Dec14_CLL_A_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_8.raw	54	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-49	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_8	proteomic profiling by mass spectrometry	17Dec14_CLL_A_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_8.raw	54	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-49	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_8	proteomic profiling by mass spectrometry	17Dec14_CLL_A_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_8.raw	54	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-49	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_8	proteomic profiling by mass spectrometry	17Dec14_CLL_A_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_8.raw	54	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-49	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_8	proteomic profiling by mass spectrometry	17Dec14_CLL_A_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_8.raw	54	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-49	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_8	proteomic profiling by mass spectrometry	17Dec14_CLL_A_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_8.raw	54	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-50	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_8	proteomic profiling by mass spectrometry	17Dec14_CLL_A_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_8.raw	54	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-50	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_9	proteomic profiling by mass spectrometry	17Dec14_CLL_A_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_9.raw	55	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-50	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_9	proteomic profiling by mass spectrometry	17Dec14_CLL_A_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_9.raw	55	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-50	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_A_9	proteomic profiling by mass spectrometry	17Dec14_CLL_A_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_9.raw	55	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-50	Homo sapiens	blood	B cell	not available	not applicable	not applicable	4	1	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_9	proteomic profiling by mass spectrometry	17Dec14_CLL_A_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_9.raw	55	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-50	Homo sapiens	blood	B cell	not available	not applicable	not applicable	5	2	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_9	proteomic profiling by mass spectrometry	17Dec14_CLL_A_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_9.raw	55	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-50	Homo sapiens	blood	B cell	not available	not applicable	not applicable	6	3	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_9	proteomic profiling by mass spectrometry	17Dec14_CLL_A_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_9.raw	55	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-50	Homo sapiens	blood	B cell	not available	not applicable	not applicable	7	4	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_9	proteomic profiling by mass spectrometry	17Dec14_CLL_A_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_9.raw	55	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-50	Homo sapiens	blood	B cell	not available	not applicable	not applicable	8	5	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_9	proteomic profiling by mass spectrometry	17Dec14_CLL_A_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_9.raw	55	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-50	Homo sapiens	blood	B cell	not available	not applicable	not applicable	9	6	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_9	proteomic profiling by mass spectrometry	17Dec14_CLL_A_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_9.raw	55	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-50	Homo sapiens	blood	B cell	not available	not applicable	not applicable	10	7	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_A_9	proteomic profiling by mass spectrometry	17Dec14_CLL_A_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_A_9.raw	55	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-51	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_1	proteomic profiling by mass spectrometry	17Dec14_CLL_B_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_1.raw	56	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-51	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_1	proteomic profiling by mass spectrometry	17Dec14_CLL_B_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_1.raw	56	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-51	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_1	proteomic profiling by mass spectrometry	17Dec14_CLL_B_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_1.raw	56	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-51	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_1	proteomic profiling by mass spectrometry	17Dec14_CLL_B_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_1.raw	56	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-51	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_1	proteomic profiling by mass spectrometry	17Dec14_CLL_B_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_1.raw	56	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-51	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_1	proteomic profiling by mass spectrometry	17Dec14_CLL_B_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_1.raw	56	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-51	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_1	proteomic profiling by mass spectrometry	17Dec14_CLL_B_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_1.raw	56	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-51	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_1	proteomic profiling by mass spectrometry	17Dec14_CLL_B_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_1.raw	56	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-51	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_1	proteomic profiling by mass spectrometry	17Dec14_CLL_B_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_1.raw	56	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-51	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_1	proteomic profiling by mass spectrometry	17Dec14_CLL_B_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_1.raw	56	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-51	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_10	proteomic profiling by mass spectrometry	17Dec14_CLL_B_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_10.raw	57	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-52	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_10	proteomic profiling by mass spectrometry	17Dec14_CLL_B_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_10.raw	57	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-52	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_10	proteomic profiling by mass spectrometry	17Dec14_CLL_B_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_10.raw	57	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-52	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_10	proteomic profiling by mass spectrometry	17Dec14_CLL_B_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_10.raw	57	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-52	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_10	proteomic profiling by mass spectrometry	17Dec14_CLL_B_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_10.raw	57	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-52	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_10	proteomic profiling by mass spectrometry	17Dec14_CLL_B_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_10.raw	57	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-52	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_10	proteomic profiling by mass spectrometry	17Dec14_CLL_B_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_10.raw	57	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-52	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_10	proteomic profiling by mass spectrometry	17Dec14_CLL_B_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_10.raw	57	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-52	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_10	proteomic profiling by mass spectrometry	17Dec14_CLL_B_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_10.raw	57	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-52	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_10	proteomic profiling by mass spectrometry	17Dec14_CLL_B_10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_10.raw	57	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-52	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_19	proteomic profiling by mass spectrometry	17Dec14_CLL_B_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_19.raw	58	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-52	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_19	proteomic profiling by mass spectrometry	17Dec14_CLL_B_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_19.raw	58	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-53	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_19	proteomic profiling by mass spectrometry	17Dec14_CLL_B_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_19.raw	58	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-53	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_19	proteomic profiling by mass spectrometry	17Dec14_CLL_B_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_19.raw	58	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-53	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_19	proteomic profiling by mass spectrometry	17Dec14_CLL_B_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_19.raw	58	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-53	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_19	proteomic profiling by mass spectrometry	17Dec14_CLL_B_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_19.raw	58	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-53	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_19	proteomic profiling by mass spectrometry	17Dec14_CLL_B_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_19.raw	58	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-53	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_19	proteomic profiling by mass spectrometry	17Dec14_CLL_B_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_19.raw	58	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-53	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_19	proteomic profiling by mass spectrometry	17Dec14_CLL_B_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_19.raw	58	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-53	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_19	proteomic profiling by mass spectrometry	17Dec14_CLL_B_19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_19.raw	58	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-53	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_2	proteomic profiling by mass spectrometry	17Dec14_CLL_B_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_2.raw	59	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-53	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_2	proteomic profiling by mass spectrometry	17Dec14_CLL_B_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_2.raw	59	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-53	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_2	proteomic profiling by mass spectrometry	17Dec14_CLL_B_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_2.raw	59	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-54	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_2	proteomic profiling by mass spectrometry	17Dec14_CLL_B_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_2.raw	59	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-54	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_2	proteomic profiling by mass spectrometry	17Dec14_CLL_B_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_2.raw	59	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-54	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_2	proteomic profiling by mass spectrometry	17Dec14_CLL_B_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_2.raw	59	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-54	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_2	proteomic profiling by mass spectrometry	17Dec14_CLL_B_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_2.raw	59	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-54	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_2	proteomic profiling by mass spectrometry	17Dec14_CLL_B_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_2.raw	59	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-54	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_2	proteomic profiling by mass spectrometry	17Dec14_CLL_B_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_2.raw	59	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-54	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_2	proteomic profiling by mass spectrometry	17Dec14_CLL_B_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_2.raw	59	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-54	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_20	proteomic profiling by mass spectrometry	17Dec14_CLL_B_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_20.raw	60	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-54	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_20	proteomic profiling by mass spectrometry	17Dec14_CLL_B_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_20.raw	60	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-54	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_20	proteomic profiling by mass spectrometry	17Dec14_CLL_B_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_20.raw	60	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-54	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_20	proteomic profiling by mass spectrometry	17Dec14_CLL_B_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_20.raw	60	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-55	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_20	proteomic profiling by mass spectrometry	17Dec14_CLL_B_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_20.raw	60	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-55	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_20	proteomic profiling by mass spectrometry	17Dec14_CLL_B_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_20.raw	60	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-55	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_20	proteomic profiling by mass spectrometry	17Dec14_CLL_B_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_20.raw	60	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-55	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_20	proteomic profiling by mass spectrometry	17Dec14_CLL_B_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_20.raw	60	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-55	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_20	proteomic profiling by mass spectrometry	17Dec14_CLL_B_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_20.raw	60	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-55	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_20	proteomic profiling by mass spectrometry	17Dec14_CLL_B_20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_20.raw	60	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-55	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_21	proteomic profiling by mass spectrometry	17Dec14_CLL_B_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_21.raw	61	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-55	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_21	proteomic profiling by mass spectrometry	17Dec14_CLL_B_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_21.raw	61	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-55	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_21	proteomic profiling by mass spectrometry	17Dec14_CLL_B_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_21.raw	61	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-55	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_21	proteomic profiling by mass spectrometry	17Dec14_CLL_B_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_21.raw	61	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-55	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_21	proteomic profiling by mass spectrometry	17Dec14_CLL_B_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_21.raw	61	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-56	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_21	proteomic profiling by mass spectrometry	17Dec14_CLL_B_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_21.raw	61	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-56	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_21	proteomic profiling by mass spectrometry	17Dec14_CLL_B_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_21.raw	61	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-56	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_21	proteomic profiling by mass spectrometry	17Dec14_CLL_B_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_21.raw	61	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-56	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_21	proteomic profiling by mass spectrometry	17Dec14_CLL_B_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_21.raw	61	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-56	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_21	proteomic profiling by mass spectrometry	17Dec14_CLL_B_21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_21.raw	61	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-56	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_22	proteomic profiling by mass spectrometry	17Dec14_CLL_B_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_22.raw	62	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-56	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_22	proteomic profiling by mass spectrometry	17Dec14_CLL_B_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_22.raw	62	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-56	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_22	proteomic profiling by mass spectrometry	17Dec14_CLL_B_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_22.raw	62	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-56	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_22	proteomic profiling by mass spectrometry	17Dec14_CLL_B_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_22.raw	62	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-56	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_22	proteomic profiling by mass spectrometry	17Dec14_CLL_B_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_22.raw	62	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-56	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_22	proteomic profiling by mass spectrometry	17Dec14_CLL_B_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_22.raw	62	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-57	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_22	proteomic profiling by mass spectrometry	17Dec14_CLL_B_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_22.raw	62	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-57	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_22	proteomic profiling by mass spectrometry	17Dec14_CLL_B_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_22.raw	62	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-57	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_22	proteomic profiling by mass spectrometry	17Dec14_CLL_B_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_22.raw	62	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-57	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_22	proteomic profiling by mass spectrometry	17Dec14_CLL_B_22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_22.raw	62	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-57	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_23	proteomic profiling by mass spectrometry	17Dec14_CLL_B_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_23.raw	63	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-57	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_23	proteomic profiling by mass spectrometry	17Dec14_CLL_B_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_23.raw	63	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-57	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_23	proteomic profiling by mass spectrometry	17Dec14_CLL_B_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_23.raw	63	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-57	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_23	proteomic profiling by mass spectrometry	17Dec14_CLL_B_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_23.raw	63	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-57	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_23	proteomic profiling by mass spectrometry	17Dec14_CLL_B_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_23.raw	63	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-57	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_23	proteomic profiling by mass spectrometry	17Dec14_CLL_B_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_23.raw	63	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-57	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_23	proteomic profiling by mass spectrometry	17Dec14_CLL_B_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_23.raw	63	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-58	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_23	proteomic profiling by mass spectrometry	17Dec14_CLL_B_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_23.raw	63	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-58	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_23	proteomic profiling by mass spectrometry	17Dec14_CLL_B_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_23.raw	63	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-58	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_23	proteomic profiling by mass spectrometry	17Dec14_CLL_B_23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_23.raw	63	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-58	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_24	proteomic profiling by mass spectrometry	17Dec14_CLL_B_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_24.raw	64	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-58	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_24	proteomic profiling by mass spectrometry	17Dec14_CLL_B_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_24.raw	64	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-58	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_24	proteomic profiling by mass spectrometry	17Dec14_CLL_B_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_24.raw	64	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-58	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_24	proteomic profiling by mass spectrometry	17Dec14_CLL_B_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_24.raw	64	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-58	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_24	proteomic profiling by mass spectrometry	17Dec14_CLL_B_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_24.raw	64	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-58	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_24	proteomic profiling by mass spectrometry	17Dec14_CLL_B_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_24.raw	64	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-58	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_24	proteomic profiling by mass spectrometry	17Dec14_CLL_B_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_24.raw	64	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-58	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_24	proteomic profiling by mass spectrometry	17Dec14_CLL_B_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_24.raw	64	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-59	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_24	proteomic profiling by mass spectrometry	17Dec14_CLL_B_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_24.raw	64	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-59	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_24	proteomic profiling by mass spectrometry	17Dec14_CLL_B_24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_24.raw	64	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-59	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_25	proteomic profiling by mass spectrometry	17Dec14_CLL_B_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_25.raw	65	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-59	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_25	proteomic profiling by mass spectrometry	17Dec14_CLL_B_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_25.raw	65	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-59	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_25	proteomic profiling by mass spectrometry	17Dec14_CLL_B_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_25.raw	65	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-59	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_25	proteomic profiling by mass spectrometry	17Dec14_CLL_B_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_25.raw	65	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-59	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_25	proteomic profiling by mass spectrometry	17Dec14_CLL_B_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_25.raw	65	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-59	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_25	proteomic profiling by mass spectrometry	17Dec14_CLL_B_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_25.raw	65	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-59	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_25	proteomic profiling by mass spectrometry	17Dec14_CLL_B_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_25.raw	65	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-59	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_25	proteomic profiling by mass spectrometry	17Dec14_CLL_B_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_25.raw	65	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-59	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_25	proteomic profiling by mass spectrometry	17Dec14_CLL_B_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_25.raw	65	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-60	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_25	proteomic profiling by mass spectrometry	17Dec14_CLL_B_25.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_25.raw	65	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-60	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_26	proteomic profiling by mass spectrometry	17Dec14_CLL_B_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_26.raw	66	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-60	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_26	proteomic profiling by mass spectrometry	17Dec14_CLL_B_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_26.raw	66	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-60	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_26	proteomic profiling by mass spectrometry	17Dec14_CLL_B_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_26.raw	66	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-60	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_26	proteomic profiling by mass spectrometry	17Dec14_CLL_B_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_26.raw	66	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-60	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_26	proteomic profiling by mass spectrometry	17Dec14_CLL_B_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_26.raw	66	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-60	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_26	proteomic profiling by mass spectrometry	17Dec14_CLL_B_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_26.raw	66	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-60	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_26	proteomic profiling by mass spectrometry	17Dec14_CLL_B_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_26.raw	66	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-60	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_26	proteomic profiling by mass spectrometry	17Dec14_CLL_B_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_26.raw	66	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-60	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_26	proteomic profiling by mass spectrometry	17Dec14_CLL_B_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_26.raw	66	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-60	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_26	proteomic profiling by mass spectrometry	17Dec14_CLL_B_26.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_26.raw	66	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-61	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_28	proteomic profiling by mass spectrometry	17Dec14_CLL_B_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_28.raw	67	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-61	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_28	proteomic profiling by mass spectrometry	17Dec14_CLL_B_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_28.raw	67	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-61	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_28	proteomic profiling by mass spectrometry	17Dec14_CLL_B_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_28.raw	67	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-61	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_28	proteomic profiling by mass spectrometry	17Dec14_CLL_B_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_28.raw	67	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-61	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_28	proteomic profiling by mass spectrometry	17Dec14_CLL_B_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_28.raw	67	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-61	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_28	proteomic profiling by mass spectrometry	17Dec14_CLL_B_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_28.raw	67	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-61	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_28	proteomic profiling by mass spectrometry	17Dec14_CLL_B_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_28.raw	67	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-61	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_28	proteomic profiling by mass spectrometry	17Dec14_CLL_B_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_28.raw	67	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-61	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_28	proteomic profiling by mass spectrometry	17Dec14_CLL_B_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_28.raw	67	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-61	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_28	proteomic profiling by mass spectrometry	17Dec14_CLL_B_28.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_28.raw	67	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-61	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_3	proteomic profiling by mass spectrometry	17Dec14_CLL_B_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_3.raw	68	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-62	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_3	proteomic profiling by mass spectrometry	17Dec14_CLL_B_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_3.raw	68	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-62	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_3	proteomic profiling by mass spectrometry	17Dec14_CLL_B_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_3.raw	68	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-62	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_3	proteomic profiling by mass spectrometry	17Dec14_CLL_B_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_3.raw	68	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-62	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_3	proteomic profiling by mass spectrometry	17Dec14_CLL_B_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_3.raw	68	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-62	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_3	proteomic profiling by mass spectrometry	17Dec14_CLL_B_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_3.raw	68	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-62	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_3	proteomic profiling by mass spectrometry	17Dec14_CLL_B_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_3.raw	68	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-62	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_3	proteomic profiling by mass spectrometry	17Dec14_CLL_B_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_3.raw	68	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-62	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_3	proteomic profiling by mass spectrometry	17Dec14_CLL_B_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_3.raw	68	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-62	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_3	proteomic profiling by mass spectrometry	17Dec14_CLL_B_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_3.raw	68	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-62	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_30	proteomic profiling by mass spectrometry	17Dec14_CLL_B_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_30.raw	69	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-62	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_30	proteomic profiling by mass spectrometry	17Dec14_CLL_B_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_30.raw	69	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-63	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_30	proteomic profiling by mass spectrometry	17Dec14_CLL_B_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_30.raw	69	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-63	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_30	proteomic profiling by mass spectrometry	17Dec14_CLL_B_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_30.raw	69	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-63	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_30	proteomic profiling by mass spectrometry	17Dec14_CLL_B_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_30.raw	69	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-63	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_30	proteomic profiling by mass spectrometry	17Dec14_CLL_B_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_30.raw	69	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-63	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_30	proteomic profiling by mass spectrometry	17Dec14_CLL_B_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_30.raw	69	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-63	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_30	proteomic profiling by mass spectrometry	17Dec14_CLL_B_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_30.raw	69	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-63	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_30	proteomic profiling by mass spectrometry	17Dec14_CLL_B_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_30.raw	69	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-63	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_30	proteomic profiling by mass spectrometry	17Dec14_CLL_B_30.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_30.raw	69	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-63	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_31	proteomic profiling by mass spectrometry	17Dec14_CLL_B_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_31.raw	70	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-63	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_31	proteomic profiling by mass spectrometry	17Dec14_CLL_B_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_31.raw	70	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-63	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_31	proteomic profiling by mass spectrometry	17Dec14_CLL_B_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_31.raw	70	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-64	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_31	proteomic profiling by mass spectrometry	17Dec14_CLL_B_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_31.raw	70	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-64	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_31	proteomic profiling by mass spectrometry	17Dec14_CLL_B_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_31.raw	70	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-64	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_31	proteomic profiling by mass spectrometry	17Dec14_CLL_B_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_31.raw	70	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-64	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_31	proteomic profiling by mass spectrometry	17Dec14_CLL_B_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_31.raw	70	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-64	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_31	proteomic profiling by mass spectrometry	17Dec14_CLL_B_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_31.raw	70	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-64	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_31	proteomic profiling by mass spectrometry	17Dec14_CLL_B_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_31.raw	70	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-64	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_31	proteomic profiling by mass spectrometry	17Dec14_CLL_B_31.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_31.raw	70	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-64	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_32	proteomic profiling by mass spectrometry	17Dec14_CLL_B_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_32.raw	71	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-64	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_32	proteomic profiling by mass spectrometry	17Dec14_CLL_B_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_32.raw	71	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-64	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_32	proteomic profiling by mass spectrometry	17Dec14_CLL_B_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_32.raw	71	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-64	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_32	proteomic profiling by mass spectrometry	17Dec14_CLL_B_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_32.raw	71	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-65	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_32	proteomic profiling by mass spectrometry	17Dec14_CLL_B_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_32.raw	71	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-65	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_32	proteomic profiling by mass spectrometry	17Dec14_CLL_B_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_32.raw	71	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-65	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_32	proteomic profiling by mass spectrometry	17Dec14_CLL_B_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_32.raw	71	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-65	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_32	proteomic profiling by mass spectrometry	17Dec14_CLL_B_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_32.raw	71	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-65	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_32	proteomic profiling by mass spectrometry	17Dec14_CLL_B_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_32.raw	71	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-65	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_32	proteomic profiling by mass spectrometry	17Dec14_CLL_B_32.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_32.raw	71	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-65	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_33	proteomic profiling by mass spectrometry	17Dec14_CLL_B_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_33.raw	72	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-65	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_33	proteomic profiling by mass spectrometry	17Dec14_CLL_B_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_33.raw	72	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-65	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_33	proteomic profiling by mass spectrometry	17Dec14_CLL_B_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_33.raw	72	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-65	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_33	proteomic profiling by mass spectrometry	17Dec14_CLL_B_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_33.raw	72	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-65	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_33	proteomic profiling by mass spectrometry	17Dec14_CLL_B_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_33.raw	72	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-66	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_33	proteomic profiling by mass spectrometry	17Dec14_CLL_B_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_33.raw	72	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-66	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_33	proteomic profiling by mass spectrometry	17Dec14_CLL_B_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_33.raw	72	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-66	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_33	proteomic profiling by mass spectrometry	17Dec14_CLL_B_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_33.raw	72	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-66	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_33	proteomic profiling by mass spectrometry	17Dec14_CLL_B_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_33.raw	72	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-66	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_33	proteomic profiling by mass spectrometry	17Dec14_CLL_B_33.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_33.raw	72	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-66	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_34	proteomic profiling by mass spectrometry	17Dec14_CLL_B_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_34.raw	73	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-66	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_34	proteomic profiling by mass spectrometry	17Dec14_CLL_B_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_34.raw	73	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-66	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_34	proteomic profiling by mass spectrometry	17Dec14_CLL_B_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_34.raw	73	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-66	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_34	proteomic profiling by mass spectrometry	17Dec14_CLL_B_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_34.raw	73	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-66	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_34	proteomic profiling by mass spectrometry	17Dec14_CLL_B_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_34.raw	73	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-66	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_34	proteomic profiling by mass spectrometry	17Dec14_CLL_B_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_34.raw	73	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-67	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_34	proteomic profiling by mass spectrometry	17Dec14_CLL_B_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_34.raw	73	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-67	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_34	proteomic profiling by mass spectrometry	17Dec14_CLL_B_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_34.raw	73	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-67	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_34	proteomic profiling by mass spectrometry	17Dec14_CLL_B_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_34.raw	73	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-67	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_34	proteomic profiling by mass spectrometry	17Dec14_CLL_B_34.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_34.raw	73	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-67	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_35	proteomic profiling by mass spectrometry	17Dec14_CLL_B_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_35.raw	74	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-67	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_35	proteomic profiling by mass spectrometry	17Dec14_CLL_B_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_35.raw	74	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-67	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_35	proteomic profiling by mass spectrometry	17Dec14_CLL_B_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_35.raw	74	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-67	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_35	proteomic profiling by mass spectrometry	17Dec14_CLL_B_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_35.raw	74	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-67	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_35	proteomic profiling by mass spectrometry	17Dec14_CLL_B_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_35.raw	74	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-67	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_35	proteomic profiling by mass spectrometry	17Dec14_CLL_B_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_35.raw	74	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-67	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_35	proteomic profiling by mass spectrometry	17Dec14_CLL_B_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_35.raw	74	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-68	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_35	proteomic profiling by mass spectrometry	17Dec14_CLL_B_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_35.raw	74	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-68	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_35	proteomic profiling by mass spectrometry	17Dec14_CLL_B_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_35.raw	74	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-68	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_35	proteomic profiling by mass spectrometry	17Dec14_CLL_B_35.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_35.raw	74	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-68	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_36	proteomic profiling by mass spectrometry	17Dec14_CLL_B_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_36.raw	75	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-68	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_36	proteomic profiling by mass spectrometry	17Dec14_CLL_B_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_36.raw	75	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-68	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_36	proteomic profiling by mass spectrometry	17Dec14_CLL_B_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_36.raw	75	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-68	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_36	proteomic profiling by mass spectrometry	17Dec14_CLL_B_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_36.raw	75	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-68	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_36	proteomic profiling by mass spectrometry	17Dec14_CLL_B_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_36.raw	75	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-68	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_36	proteomic profiling by mass spectrometry	17Dec14_CLL_B_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_36.raw	75	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-68	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_36	proteomic profiling by mass spectrometry	17Dec14_CLL_B_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_36.raw	75	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-68	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_36	proteomic profiling by mass spectrometry	17Dec14_CLL_B_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_36.raw	75	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-69	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_36	proteomic profiling by mass spectrometry	17Dec14_CLL_B_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_36.raw	75	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-69	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_36	proteomic profiling by mass spectrometry	17Dec14_CLL_B_36.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_36.raw	75	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-69	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_37	proteomic profiling by mass spectrometry	17Dec14_CLL_B_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_37.raw	76	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-69	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_37	proteomic profiling by mass spectrometry	17Dec14_CLL_B_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_37.raw	76	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-69	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_37	proteomic profiling by mass spectrometry	17Dec14_CLL_B_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_37.raw	76	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-69	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_37	proteomic profiling by mass spectrometry	17Dec14_CLL_B_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_37.raw	76	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-69	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_37	proteomic profiling by mass spectrometry	17Dec14_CLL_B_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_37.raw	76	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-69	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_37	proteomic profiling by mass spectrometry	17Dec14_CLL_B_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_37.raw	76	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-69	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_37	proteomic profiling by mass spectrometry	17Dec14_CLL_B_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_37.raw	76	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-69	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_37	proteomic profiling by mass spectrometry	17Dec14_CLL_B_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_37.raw	76	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-69	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_37	proteomic profiling by mass spectrometry	17Dec14_CLL_B_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_37.raw	76	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-70	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_37	proteomic profiling by mass spectrometry	17Dec14_CLL_B_37.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_37.raw	76	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-70	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_38	proteomic profiling by mass spectrometry	17Dec14_CLL_B_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_38.raw	77	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-70	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_38	proteomic profiling by mass spectrometry	17Dec14_CLL_B_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_38.raw	77	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-70	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_38	proteomic profiling by mass spectrometry	17Dec14_CLL_B_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_38.raw	77	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-70	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_38	proteomic profiling by mass spectrometry	17Dec14_CLL_B_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_38.raw	77	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-70	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_38	proteomic profiling by mass spectrometry	17Dec14_CLL_B_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_38.raw	77	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-70	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_38	proteomic profiling by mass spectrometry	17Dec14_CLL_B_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_38.raw	77	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-70	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_38	proteomic profiling by mass spectrometry	17Dec14_CLL_B_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_38.raw	77	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-70	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_38	proteomic profiling by mass spectrometry	17Dec14_CLL_B_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_38.raw	77	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-70	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_38	proteomic profiling by mass spectrometry	17Dec14_CLL_B_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_38.raw	77	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-70	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_38	proteomic profiling by mass spectrometry	17Dec14_CLL_B_38.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_38.raw	77	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-71	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_39	proteomic profiling by mass spectrometry	17Dec14_CLL_B_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_39.raw	78	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-71	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_39	proteomic profiling by mass spectrometry	17Dec14_CLL_B_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_39.raw	78	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-71	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_39	proteomic profiling by mass spectrometry	17Dec14_CLL_B_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_39.raw	78	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-71	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_39	proteomic profiling by mass spectrometry	17Dec14_CLL_B_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_39.raw	78	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-71	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_39	proteomic profiling by mass spectrometry	17Dec14_CLL_B_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_39.raw	78	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-71	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_39	proteomic profiling by mass spectrometry	17Dec14_CLL_B_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_39.raw	78	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-71	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_39	proteomic profiling by mass spectrometry	17Dec14_CLL_B_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_39.raw	78	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-71	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_39	proteomic profiling by mass spectrometry	17Dec14_CLL_B_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_39.raw	78	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-71	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_39	proteomic profiling by mass spectrometry	17Dec14_CLL_B_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_39.raw	78	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-71	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_39	proteomic profiling by mass spectrometry	17Dec14_CLL_B_39.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_39.raw	78	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-71	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_4	proteomic profiling by mass spectrometry	17Dec14_CLL_B_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_4.raw	79	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-72	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_4	proteomic profiling by mass spectrometry	17Dec14_CLL_B_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_4.raw	79	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-72	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_4	proteomic profiling by mass spectrometry	17Dec14_CLL_B_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_4.raw	79	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-72	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_4	proteomic profiling by mass spectrometry	17Dec14_CLL_B_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_4.raw	79	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-72	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_4	proteomic profiling by mass spectrometry	17Dec14_CLL_B_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_4.raw	79	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-72	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_4	proteomic profiling by mass spectrometry	17Dec14_CLL_B_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_4.raw	79	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-72	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_4	proteomic profiling by mass spectrometry	17Dec14_CLL_B_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_4.raw	79	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-72	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_4	proteomic profiling by mass spectrometry	17Dec14_CLL_B_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_4.raw	79	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-72	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_4	proteomic profiling by mass spectrometry	17Dec14_CLL_B_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_4.raw	79	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-72	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_4	proteomic profiling by mass spectrometry	17Dec14_CLL_B_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_4.raw	79	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-72	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_40	proteomic profiling by mass spectrometry	17Dec14_CLL_B_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_40.raw	80	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-72	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_40	proteomic profiling by mass spectrometry	17Dec14_CLL_B_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_40.raw	80	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-73	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_40	proteomic profiling by mass spectrometry	17Dec14_CLL_B_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_40.raw	80	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-73	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_40	proteomic profiling by mass spectrometry	17Dec14_CLL_B_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_40.raw	80	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-73	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_40	proteomic profiling by mass spectrometry	17Dec14_CLL_B_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_40.raw	80	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-73	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_40	proteomic profiling by mass spectrometry	17Dec14_CLL_B_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_40.raw	80	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-73	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_40	proteomic profiling by mass spectrometry	17Dec14_CLL_B_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_40.raw	80	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-73	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_40	proteomic profiling by mass spectrometry	17Dec14_CLL_B_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_40.raw	80	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-73	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_40	proteomic profiling by mass spectrometry	17Dec14_CLL_B_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_40.raw	80	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-73	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_40	proteomic profiling by mass spectrometry	17Dec14_CLL_B_40.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_40.raw	80	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-73	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_41	proteomic profiling by mass spectrometry	17Dec14_CLL_B_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_41.raw	81	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-73	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_41	proteomic profiling by mass spectrometry	17Dec14_CLL_B_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_41.raw	81	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-73	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_41	proteomic profiling by mass spectrometry	17Dec14_CLL_B_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_41.raw	81	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-74	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_41	proteomic profiling by mass spectrometry	17Dec14_CLL_B_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_41.raw	81	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-74	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_41	proteomic profiling by mass spectrometry	17Dec14_CLL_B_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_41.raw	81	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-74	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_41	proteomic profiling by mass spectrometry	17Dec14_CLL_B_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_41.raw	81	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-74	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_41	proteomic profiling by mass spectrometry	17Dec14_CLL_B_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_41.raw	81	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-74	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_41	proteomic profiling by mass spectrometry	17Dec14_CLL_B_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_41.raw	81	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-74	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_41	proteomic profiling by mass spectrometry	17Dec14_CLL_B_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_41.raw	81	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-74	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_41	proteomic profiling by mass spectrometry	17Dec14_CLL_B_41.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_41.raw	81	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-74	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_42	proteomic profiling by mass spectrometry	17Dec14_CLL_B_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_42.raw	82	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-74	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_42	proteomic profiling by mass spectrometry	17Dec14_CLL_B_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_42.raw	82	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-74	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_42	proteomic profiling by mass spectrometry	17Dec14_CLL_B_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_42.raw	82	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-74	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_42	proteomic profiling by mass spectrometry	17Dec14_CLL_B_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_42.raw	82	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-75	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_42	proteomic profiling by mass spectrometry	17Dec14_CLL_B_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_42.raw	82	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-75	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_42	proteomic profiling by mass spectrometry	17Dec14_CLL_B_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_42.raw	82	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-75	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_42	proteomic profiling by mass spectrometry	17Dec14_CLL_B_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_42.raw	82	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-75	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_42	proteomic profiling by mass spectrometry	17Dec14_CLL_B_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_42.raw	82	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-75	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_42	proteomic profiling by mass spectrometry	17Dec14_CLL_B_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_42.raw	82	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-75	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_42	proteomic profiling by mass spectrometry	17Dec14_CLL_B_42.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_42.raw	82	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-75	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_43	proteomic profiling by mass spectrometry	17Dec14_CLL_B_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_43.raw	83	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-75	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_43	proteomic profiling by mass spectrometry	17Dec14_CLL_B_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_43.raw	83	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-75	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_43	proteomic profiling by mass spectrometry	17Dec14_CLL_B_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_43.raw	83	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-75	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_43	proteomic profiling by mass spectrometry	17Dec14_CLL_B_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_43.raw	83	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-75	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_43	proteomic profiling by mass spectrometry	17Dec14_CLL_B_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_43.raw	83	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-76	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_43	proteomic profiling by mass spectrometry	17Dec14_CLL_B_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_43.raw	83	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-76	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_43	proteomic profiling by mass spectrometry	17Dec14_CLL_B_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_43.raw	83	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-76	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_43	proteomic profiling by mass spectrometry	17Dec14_CLL_B_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_43.raw	83	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-76	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_43	proteomic profiling by mass spectrometry	17Dec14_CLL_B_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_43.raw	83	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-76	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_43	proteomic profiling by mass spectrometry	17Dec14_CLL_B_43.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_43.raw	83	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-76	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_44	proteomic profiling by mass spectrometry	17Dec14_CLL_B_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_44.raw	84	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-76	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_44	proteomic profiling by mass spectrometry	17Dec14_CLL_B_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_44.raw	84	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-76	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_44	proteomic profiling by mass spectrometry	17Dec14_CLL_B_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_44.raw	84	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-76	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_44	proteomic profiling by mass spectrometry	17Dec14_CLL_B_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_44.raw	84	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-76	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_44	proteomic profiling by mass spectrometry	17Dec14_CLL_B_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_44.raw	84	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-76	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_44	proteomic profiling by mass spectrometry	17Dec14_CLL_B_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_44.raw	84	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-77	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_44	proteomic profiling by mass spectrometry	17Dec14_CLL_B_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_44.raw	84	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-77	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_44	proteomic profiling by mass spectrometry	17Dec14_CLL_B_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_44.raw	84	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-77	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_44	proteomic profiling by mass spectrometry	17Dec14_CLL_B_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_44.raw	84	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-77	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_44	proteomic profiling by mass spectrometry	17Dec14_CLL_B_44.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_44.raw	84	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-77	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_45	proteomic profiling by mass spectrometry	17Dec14_CLL_B_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_45.raw	85	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-77	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_45	proteomic profiling by mass spectrometry	17Dec14_CLL_B_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_45.raw	85	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-77	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_45	proteomic profiling by mass spectrometry	17Dec14_CLL_B_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_45.raw	85	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-77	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_45	proteomic profiling by mass spectrometry	17Dec14_CLL_B_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_45.raw	85	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-77	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_45	proteomic profiling by mass spectrometry	17Dec14_CLL_B_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_45.raw	85	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-77	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_45	proteomic profiling by mass spectrometry	17Dec14_CLL_B_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_45.raw	85	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-77	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_45	proteomic profiling by mass spectrometry	17Dec14_CLL_B_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_45.raw	85	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-78	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_45	proteomic profiling by mass spectrometry	17Dec14_CLL_B_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_45.raw	85	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-78	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_45	proteomic profiling by mass spectrometry	17Dec14_CLL_B_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_45.raw	85	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-78	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_45	proteomic profiling by mass spectrometry	17Dec14_CLL_B_45.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_45.raw	85	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-78	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_46	proteomic profiling by mass spectrometry	17Dec14_CLL_B_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_46.raw	86	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-78	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_46	proteomic profiling by mass spectrometry	17Dec14_CLL_B_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_46.raw	86	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-78	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_46	proteomic profiling by mass spectrometry	17Dec14_CLL_B_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_46.raw	86	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-78	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_46	proteomic profiling by mass spectrometry	17Dec14_CLL_B_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_46.raw	86	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-78	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_46	proteomic profiling by mass spectrometry	17Dec14_CLL_B_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_46.raw	86	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-78	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_46	proteomic profiling by mass spectrometry	17Dec14_CLL_B_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_46.raw	86	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-78	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_46	proteomic profiling by mass spectrometry	17Dec14_CLL_B_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_46.raw	86	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-78	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_46	proteomic profiling by mass spectrometry	17Dec14_CLL_B_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_46.raw	86	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-79	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_46	proteomic profiling by mass spectrometry	17Dec14_CLL_B_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_46.raw	86	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-79	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_46	proteomic profiling by mass spectrometry	17Dec14_CLL_B_46.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_46.raw	86	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-79	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_47	proteomic profiling by mass spectrometry	17Dec14_CLL_B_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_47.raw	87	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-79	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_47	proteomic profiling by mass spectrometry	17Dec14_CLL_B_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_47.raw	87	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-79	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_47	proteomic profiling by mass spectrometry	17Dec14_CLL_B_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_47.raw	87	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-79	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_47	proteomic profiling by mass spectrometry	17Dec14_CLL_B_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_47.raw	87	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-79	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_47	proteomic profiling by mass spectrometry	17Dec14_CLL_B_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_47.raw	87	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-79	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_47	proteomic profiling by mass spectrometry	17Dec14_CLL_B_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_47.raw	87	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-79	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_47	proteomic profiling by mass spectrometry	17Dec14_CLL_B_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_47.raw	87	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-79	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_47	proteomic profiling by mass spectrometry	17Dec14_CLL_B_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_47.raw	87	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-79	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_47	proteomic profiling by mass spectrometry	17Dec14_CLL_B_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_47.raw	87	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-80	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_47	proteomic profiling by mass spectrometry	17Dec14_CLL_B_47.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_47.raw	87	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-80	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_48	proteomic profiling by mass spectrometry	17Dec14_CLL_B_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_48.raw	88	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-80	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_48	proteomic profiling by mass spectrometry	17Dec14_CLL_B_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_48.raw	88	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-80	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_48	proteomic profiling by mass spectrometry	17Dec14_CLL_B_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_48.raw	88	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-80	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_48	proteomic profiling by mass spectrometry	17Dec14_CLL_B_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_48.raw	88	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-80	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_48	proteomic profiling by mass spectrometry	17Dec14_CLL_B_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_48.raw	88	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-80	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_48	proteomic profiling by mass spectrometry	17Dec14_CLL_B_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_48.raw	88	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-80	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_48	proteomic profiling by mass spectrometry	17Dec14_CLL_B_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_48.raw	88	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-80	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_48	proteomic profiling by mass spectrometry	17Dec14_CLL_B_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_48.raw	88	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-80	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_48	proteomic profiling by mass spectrometry	17Dec14_CLL_B_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_48.raw	88	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-80	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_48	proteomic profiling by mass spectrometry	17Dec14_CLL_B_48.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_48.raw	88	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-81	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_49	proteomic profiling by mass spectrometry	17Dec14_CLL_B_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_49.raw	89	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-81	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_49	proteomic profiling by mass spectrometry	17Dec14_CLL_B_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_49.raw	89	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-81	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_49	proteomic profiling by mass spectrometry	17Dec14_CLL_B_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_49.raw	89	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-81	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_49	proteomic profiling by mass spectrometry	17Dec14_CLL_B_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_49.raw	89	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-81	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_49	proteomic profiling by mass spectrometry	17Dec14_CLL_B_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_49.raw	89	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-81	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_49	proteomic profiling by mass spectrometry	17Dec14_CLL_B_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_49.raw	89	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-81	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_49	proteomic profiling by mass spectrometry	17Dec14_CLL_B_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_49.raw	89	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-81	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_49	proteomic profiling by mass spectrometry	17Dec14_CLL_B_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_49.raw	89	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-81	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_49	proteomic profiling by mass spectrometry	17Dec14_CLL_B_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_49.raw	89	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-81	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_49	proteomic profiling by mass spectrometry	17Dec14_CLL_B_49.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_49.raw	89	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-81	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_5	proteomic profiling by mass spectrometry	17Dec14_CLL_B_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_5.raw	90	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-82	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_5	proteomic profiling by mass spectrometry	17Dec14_CLL_B_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_5.raw	90	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-82	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_5	proteomic profiling by mass spectrometry	17Dec14_CLL_B_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_5.raw	90	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-82	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_5	proteomic profiling by mass spectrometry	17Dec14_CLL_B_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_5.raw	90	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-82	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_5	proteomic profiling by mass spectrometry	17Dec14_CLL_B_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_5.raw	90	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-82	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_5	proteomic profiling by mass spectrometry	17Dec14_CLL_B_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_5.raw	90	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-82	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_5	proteomic profiling by mass spectrometry	17Dec14_CLL_B_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_5.raw	90	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-82	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_5	proteomic profiling by mass spectrometry	17Dec14_CLL_B_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_5.raw	90	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-82	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_5	proteomic profiling by mass spectrometry	17Dec14_CLL_B_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_5.raw	90	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-82	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_5	proteomic profiling by mass spectrometry	17Dec14_CLL_B_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_5.raw	90	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-82	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_50	proteomic profiling by mass spectrometry	17Dec14_CLL_B_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_50.raw	91	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-82	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_50	proteomic profiling by mass spectrometry	17Dec14_CLL_B_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_50.raw	91	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-83	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_50	proteomic profiling by mass spectrometry	17Dec14_CLL_B_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_50.raw	91	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-83	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_50	proteomic profiling by mass spectrometry	17Dec14_CLL_B_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_50.raw	91	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-83	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_50	proteomic profiling by mass spectrometry	17Dec14_CLL_B_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_50.raw	91	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-83	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_50	proteomic profiling by mass spectrometry	17Dec14_CLL_B_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_50.raw	91	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-83	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_50	proteomic profiling by mass spectrometry	17Dec14_CLL_B_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_50.raw	91	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-83	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_50	proteomic profiling by mass spectrometry	17Dec14_CLL_B_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_50.raw	91	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-83	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_50	proteomic profiling by mass spectrometry	17Dec14_CLL_B_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_50.raw	91	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-83	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_50	proteomic profiling by mass spectrometry	17Dec14_CLL_B_50.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_50.raw	91	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-83	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_51	proteomic profiling by mass spectrometry	17Dec14_CLL_B_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_51.raw	92	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-83	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_51	proteomic profiling by mass spectrometry	17Dec14_CLL_B_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_51.raw	92	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-83	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_51	proteomic profiling by mass spectrometry	17Dec14_CLL_B_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_51.raw	92	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-84	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_51	proteomic profiling by mass spectrometry	17Dec14_CLL_B_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_51.raw	92	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-84	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_51	proteomic profiling by mass spectrometry	17Dec14_CLL_B_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_51.raw	92	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-84	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_51	proteomic profiling by mass spectrometry	17Dec14_CLL_B_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_51.raw	92	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-84	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_51	proteomic profiling by mass spectrometry	17Dec14_CLL_B_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_51.raw	92	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-84	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_51	proteomic profiling by mass spectrometry	17Dec14_CLL_B_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_51.raw	92	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-84	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_51	proteomic profiling by mass spectrometry	17Dec14_CLL_B_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_51.raw	92	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-84	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_51	proteomic profiling by mass spectrometry	17Dec14_CLL_B_51.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_51.raw	92	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-84	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_52	proteomic profiling by mass spectrometry	17Dec14_CLL_B_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_52.raw	93	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-84	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_52	proteomic profiling by mass spectrometry	17Dec14_CLL_B_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_52.raw	93	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-84	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_52	proteomic profiling by mass spectrometry	17Dec14_CLL_B_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_52.raw	93	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-84	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_52	proteomic profiling by mass spectrometry	17Dec14_CLL_B_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_52.raw	93	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-85	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_52	proteomic profiling by mass spectrometry	17Dec14_CLL_B_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_52.raw	93	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-85	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_52	proteomic profiling by mass spectrometry	17Dec14_CLL_B_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_52.raw	93	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-85	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_52	proteomic profiling by mass spectrometry	17Dec14_CLL_B_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_52.raw	93	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-85	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_52	proteomic profiling by mass spectrometry	17Dec14_CLL_B_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_52.raw	93	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-85	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_52	proteomic profiling by mass spectrometry	17Dec14_CLL_B_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_52.raw	93	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-85	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_52	proteomic profiling by mass spectrometry	17Dec14_CLL_B_52.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_52.raw	93	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-85	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_53	proteomic profiling by mass spectrometry	17Dec14_CLL_B_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_53.raw	94	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-85	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_53	proteomic profiling by mass spectrometry	17Dec14_CLL_B_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_53.raw	94	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-85	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_53	proteomic profiling by mass spectrometry	17Dec14_CLL_B_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_53.raw	94	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-85	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_53	proteomic profiling by mass spectrometry	17Dec14_CLL_B_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_53.raw	94	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-85	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_53	proteomic profiling by mass spectrometry	17Dec14_CLL_B_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_53.raw	94	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-86	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_53	proteomic profiling by mass spectrometry	17Dec14_CLL_B_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_53.raw	94	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-86	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_53	proteomic profiling by mass spectrometry	17Dec14_CLL_B_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_53.raw	94	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-86	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_53	proteomic profiling by mass spectrometry	17Dec14_CLL_B_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_53.raw	94	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-86	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_53	proteomic profiling by mass spectrometry	17Dec14_CLL_B_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_53.raw	94	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-86	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_53	proteomic profiling by mass spectrometry	17Dec14_CLL_B_53.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_53.raw	94	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-86	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_54	proteomic profiling by mass spectrometry	17Dec14_CLL_B_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_54.raw	95	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-86	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_54	proteomic profiling by mass spectrometry	17Dec14_CLL_B_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_54.raw	95	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-86	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_54	proteomic profiling by mass spectrometry	17Dec14_CLL_B_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_54.raw	95	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-86	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_54	proteomic profiling by mass spectrometry	17Dec14_CLL_B_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_54.raw	95	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-86	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_54	proteomic profiling by mass spectrometry	17Dec14_CLL_B_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_54.raw	95	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-86	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_54	proteomic profiling by mass spectrometry	17Dec14_CLL_B_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_54.raw	95	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-87	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_54	proteomic profiling by mass spectrometry	17Dec14_CLL_B_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_54.raw	95	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-87	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_54	proteomic profiling by mass spectrometry	17Dec14_CLL_B_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_54.raw	95	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-87	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_54	proteomic profiling by mass spectrometry	17Dec14_CLL_B_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_54.raw	95	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-87	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_54	proteomic profiling by mass spectrometry	17Dec14_CLL_B_54.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_54.raw	95	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-87	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_55	proteomic profiling by mass spectrometry	17Dec14_CLL_B_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_55.raw	96	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-87	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_55	proteomic profiling by mass spectrometry	17Dec14_CLL_B_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_55.raw	96	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-87	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_55	proteomic profiling by mass spectrometry	17Dec14_CLL_B_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_55.raw	96	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-87	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_55	proteomic profiling by mass spectrometry	17Dec14_CLL_B_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_55.raw	96	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-87	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_55	proteomic profiling by mass spectrometry	17Dec14_CLL_B_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_55.raw	96	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-87	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_55	proteomic profiling by mass spectrometry	17Dec14_CLL_B_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_55.raw	96	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-87	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_55	proteomic profiling by mass spectrometry	17Dec14_CLL_B_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_55.raw	96	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-88	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_55	proteomic profiling by mass spectrometry	17Dec14_CLL_B_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_55.raw	96	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-88	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_55	proteomic profiling by mass spectrometry	17Dec14_CLL_B_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_55.raw	96	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-88	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_55	proteomic profiling by mass spectrometry	17Dec14_CLL_B_55.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_55.raw	96	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-88	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_56	proteomic profiling by mass spectrometry	17Dec14_CLL_B_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_56.raw	97	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-88	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_56	proteomic profiling by mass spectrometry	17Dec14_CLL_B_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_56.raw	97	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-88	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_56	proteomic profiling by mass spectrometry	17Dec14_CLL_B_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_56.raw	97	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-88	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_56	proteomic profiling by mass spectrometry	17Dec14_CLL_B_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_56.raw	97	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-88	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_56	proteomic profiling by mass spectrometry	17Dec14_CLL_B_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_56.raw	97	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-88	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_56	proteomic profiling by mass spectrometry	17Dec14_CLL_B_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_56.raw	97	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-88	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_56	proteomic profiling by mass spectrometry	17Dec14_CLL_B_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_56.raw	97	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-88	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_56	proteomic profiling by mass spectrometry	17Dec14_CLL_B_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_56.raw	97	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-89	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_56	proteomic profiling by mass spectrometry	17Dec14_CLL_B_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_56.raw	97	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-89	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_56	proteomic profiling by mass spectrometry	17Dec14_CLL_B_56.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_56.raw	97	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-89	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_57	proteomic profiling by mass spectrometry	17Dec14_CLL_B_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_57.raw	98	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-89	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_57	proteomic profiling by mass spectrometry	17Dec14_CLL_B_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_57.raw	98	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-89	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_57	proteomic profiling by mass spectrometry	17Dec14_CLL_B_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_57.raw	98	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-89	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_57	proteomic profiling by mass spectrometry	17Dec14_CLL_B_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_57.raw	98	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-89	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_57	proteomic profiling by mass spectrometry	17Dec14_CLL_B_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_57.raw	98	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-89	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_57	proteomic profiling by mass spectrometry	17Dec14_CLL_B_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_57.raw	98	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-89	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_57	proteomic profiling by mass spectrometry	17Dec14_CLL_B_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_57.raw	98	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-89	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_57	proteomic profiling by mass spectrometry	17Dec14_CLL_B_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_57.raw	98	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-89	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_57	proteomic profiling by mass spectrometry	17Dec14_CLL_B_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_57.raw	98	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-90	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_57	proteomic profiling by mass spectrometry	17Dec14_CLL_B_57.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_57.raw	98	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-90	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_58	proteomic profiling by mass spectrometry	17Dec14_CLL_B_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_58.raw	99	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-90	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_58	proteomic profiling by mass spectrometry	17Dec14_CLL_B_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_58.raw	99	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-90	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_58	proteomic profiling by mass spectrometry	17Dec14_CLL_B_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_58.raw	99	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-90	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_58	proteomic profiling by mass spectrometry	17Dec14_CLL_B_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_58.raw	99	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-90	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_58	proteomic profiling by mass spectrometry	17Dec14_CLL_B_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_58.raw	99	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-90	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_58	proteomic profiling by mass spectrometry	17Dec14_CLL_B_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_58.raw	99	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-90	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_58	proteomic profiling by mass spectrometry	17Dec14_CLL_B_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_58.raw	99	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-90	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_58	proteomic profiling by mass spectrometry	17Dec14_CLL_B_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_58.raw	99	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-90	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_58	proteomic profiling by mass spectrometry	17Dec14_CLL_B_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_58.raw	99	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-90	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_58	proteomic profiling by mass spectrometry	17Dec14_CLL_B_58.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_58.raw	99	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-91	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_59	proteomic profiling by mass spectrometry	17Dec14_CLL_B_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_59.raw	100	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-91	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_59	proteomic profiling by mass spectrometry	17Dec14_CLL_B_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_59.raw	100	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-91	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_59	proteomic profiling by mass spectrometry	17Dec14_CLL_B_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_59.raw	100	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-91	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_59	proteomic profiling by mass spectrometry	17Dec14_CLL_B_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_59.raw	100	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-91	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_59	proteomic profiling by mass spectrometry	17Dec14_CLL_B_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_59.raw	100	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-91	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_59	proteomic profiling by mass spectrometry	17Dec14_CLL_B_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_59.raw	100	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-91	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_59	proteomic profiling by mass spectrometry	17Dec14_CLL_B_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_59.raw	100	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-91	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_59	proteomic profiling by mass spectrometry	17Dec14_CLL_B_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_59.raw	100	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-91	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_59	proteomic profiling by mass spectrometry	17Dec14_CLL_B_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_59.raw	100	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-91	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_59	proteomic profiling by mass spectrometry	17Dec14_CLL_B_59.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_59.raw	100	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-91	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_6	proteomic profiling by mass spectrometry	17Dec14_CLL_B_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_6.raw	101	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-92	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_6	proteomic profiling by mass spectrometry	17Dec14_CLL_B_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_6.raw	101	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-92	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_6	proteomic profiling by mass spectrometry	17Dec14_CLL_B_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_6.raw	101	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-92	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_6	proteomic profiling by mass spectrometry	17Dec14_CLL_B_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_6.raw	101	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-92	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_6	proteomic profiling by mass spectrometry	17Dec14_CLL_B_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_6.raw	101	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-92	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_6	proteomic profiling by mass spectrometry	17Dec14_CLL_B_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_6.raw	101	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-92	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_6	proteomic profiling by mass spectrometry	17Dec14_CLL_B_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_6.raw	101	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-92	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_6	proteomic profiling by mass spectrometry	17Dec14_CLL_B_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_6.raw	101	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-92	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_6	proteomic profiling by mass spectrometry	17Dec14_CLL_B_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_6.raw	101	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-92	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_6	proteomic profiling by mass spectrometry	17Dec14_CLL_B_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_6.raw	101	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-92	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_60	proteomic profiling by mass spectrometry	17Dec14_CLL_B_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_60.raw	102	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-92	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_60	proteomic profiling by mass spectrometry	17Dec14_CLL_B_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_60.raw	102	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-93	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_60	proteomic profiling by mass spectrometry	17Dec14_CLL_B_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_60.raw	102	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-93	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_60	proteomic profiling by mass spectrometry	17Dec14_CLL_B_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_60.raw	102	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-93	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_60	proteomic profiling by mass spectrometry	17Dec14_CLL_B_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_60.raw	102	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-93	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_60	proteomic profiling by mass spectrometry	17Dec14_CLL_B_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_60.raw	102	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-93	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_60	proteomic profiling by mass spectrometry	17Dec14_CLL_B_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_60.raw	102	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-93	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_60	proteomic profiling by mass spectrometry	17Dec14_CLL_B_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_60.raw	102	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-93	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_60	proteomic profiling by mass spectrometry	17Dec14_CLL_B_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_60.raw	102	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-93	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_60	proteomic profiling by mass spectrometry	17Dec14_CLL_B_60.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_60.raw	102	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-93	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_61	proteomic profiling by mass spectrometry	17Dec14_CLL_B_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_61.raw	103	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-93	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_61	proteomic profiling by mass spectrometry	17Dec14_CLL_B_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_61.raw	103	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-93	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_61	proteomic profiling by mass spectrometry	17Dec14_CLL_B_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_61.raw	103	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-94	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_61	proteomic profiling by mass spectrometry	17Dec14_CLL_B_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_61.raw	103	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-94	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_61	proteomic profiling by mass spectrometry	17Dec14_CLL_B_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_61.raw	103	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-94	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_61	proteomic profiling by mass spectrometry	17Dec14_CLL_B_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_61.raw	103	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-94	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_61	proteomic profiling by mass spectrometry	17Dec14_CLL_B_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_61.raw	103	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-94	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_61	proteomic profiling by mass spectrometry	17Dec14_CLL_B_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_61.raw	103	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-94	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_61	proteomic profiling by mass spectrometry	17Dec14_CLL_B_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_61.raw	103	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-94	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_61	proteomic profiling by mass spectrometry	17Dec14_CLL_B_61.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_61.raw	103	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-94	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_62	proteomic profiling by mass spectrometry	17Dec14_CLL_B_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_62.raw	104	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-94	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_62	proteomic profiling by mass spectrometry	17Dec14_CLL_B_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_62.raw	104	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-94	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_62	proteomic profiling by mass spectrometry	17Dec14_CLL_B_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_62.raw	104	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-94	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_62	proteomic profiling by mass spectrometry	17Dec14_CLL_B_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_62.raw	104	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-95	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_62	proteomic profiling by mass spectrometry	17Dec14_CLL_B_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_62.raw	104	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-95	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_62	proteomic profiling by mass spectrometry	17Dec14_CLL_B_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_62.raw	104	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-95	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_62	proteomic profiling by mass spectrometry	17Dec14_CLL_B_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_62.raw	104	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-95	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_62	proteomic profiling by mass spectrometry	17Dec14_CLL_B_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_62.raw	104	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-95	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_62	proteomic profiling by mass spectrometry	17Dec14_CLL_B_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_62.raw	104	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-95	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_62	proteomic profiling by mass spectrometry	17Dec14_CLL_B_62.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_62.raw	104	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-95	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_63	proteomic profiling by mass spectrometry	17Dec14_CLL_B_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_63.raw	105	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-95	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_63	proteomic profiling by mass spectrometry	17Dec14_CLL_B_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_63.raw	105	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-95	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_63	proteomic profiling by mass spectrometry	17Dec14_CLL_B_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_63.raw	105	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-95	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_63	proteomic profiling by mass spectrometry	17Dec14_CLL_B_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_63.raw	105	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-95	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_63	proteomic profiling by mass spectrometry	17Dec14_CLL_B_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_63.raw	105	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-96	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_63	proteomic profiling by mass spectrometry	17Dec14_CLL_B_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_63.raw	105	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-96	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_63	proteomic profiling by mass spectrometry	17Dec14_CLL_B_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_63.raw	105	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-96	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_63	proteomic profiling by mass spectrometry	17Dec14_CLL_B_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_63.raw	105	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-96	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_63	proteomic profiling by mass spectrometry	17Dec14_CLL_B_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_63.raw	105	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-96	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_63	proteomic profiling by mass spectrometry	17Dec14_CLL_B_63.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_63.raw	105	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-96	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_7	proteomic profiling by mass spectrometry	17Dec14_CLL_B_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_7.raw	106	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-96	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_7	proteomic profiling by mass spectrometry	17Dec14_CLL_B_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_7.raw	106	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-96	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_7	proteomic profiling by mass spectrometry	17Dec14_CLL_B_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_7.raw	106	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-96	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_7	proteomic profiling by mass spectrometry	17Dec14_CLL_B_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_7.raw	106	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-96	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_7	proteomic profiling by mass spectrometry	17Dec14_CLL_B_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_7.raw	106	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-96	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_7	proteomic profiling by mass spectrometry	17Dec14_CLL_B_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_7.raw	106	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-97	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_7	proteomic profiling by mass spectrometry	17Dec14_CLL_B_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_7.raw	106	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-97	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_7	proteomic profiling by mass spectrometry	17Dec14_CLL_B_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_7.raw	106	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-97	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_7	proteomic profiling by mass spectrometry	17Dec14_CLL_B_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_7.raw	106	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-97	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_7	proteomic profiling by mass spectrometry	17Dec14_CLL_B_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_7.raw	106	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-97	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_8	proteomic profiling by mass spectrometry	17Dec14_CLL_B_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_8.raw	107	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-97	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_8	proteomic profiling by mass spectrometry	17Dec14_CLL_B_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_8.raw	107	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-97	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_8	proteomic profiling by mass spectrometry	17Dec14_CLL_B_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_8.raw	107	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-97	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_8	proteomic profiling by mass spectrometry	17Dec14_CLL_B_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_8.raw	107	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-97	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_8	proteomic profiling by mass spectrometry	17Dec14_CLL_B_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_8.raw	107	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-97	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_8	proteomic profiling by mass spectrometry	17Dec14_CLL_B_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_8.raw	107	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-97	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_8	proteomic profiling by mass spectrometry	17Dec14_CLL_B_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_8.raw	107	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-98	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_8	proteomic profiling by mass spectrometry	17Dec14_CLL_B_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_8.raw	107	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-98	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_8	proteomic profiling by mass spectrometry	17Dec14_CLL_B_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_8.raw	107	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-98	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_8	proteomic profiling by mass spectrometry	17Dec14_CLL_B_8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_8.raw	107	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-98	Homo sapiens	blood	B cell	not available	not applicable	not applicable	1	1	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_9	proteomic profiling by mass spectrometry	17Dec14_CLL_B_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_9.raw	108	1	not applicable	TMT126	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-98	Homo sapiens	blood	B cell	not available	not applicable	not applicable	2	2	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_9	proteomic profiling by mass spectrometry	17Dec14_CLL_B_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_9.raw	108	1	not applicable	TMT127N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-98	Homo sapiens	blood	B cell	not available	not applicable	not applicable	3	3	not available	not available	not available	not available	normal	no depletion	not applicable	17Dec14_CLL_B_9	proteomic profiling by mass spectrometry	17Dec14_CLL_B_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_9.raw	108	1	not applicable	TMT127C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-98	Homo sapiens	blood	B cell	not available	not applicable	not applicable	11	8	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_9	proteomic profiling by mass spectrometry	17Dec14_CLL_B_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_9.raw	108	1	not applicable	TMT128N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-98	Homo sapiens	blood	B cell	not available	not applicable	not applicable	12	9	not available	not available	female	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_9	proteomic profiling by mass spectrometry	17Dec14_CLL_B_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_9.raw	108	1	not applicable	TMT128C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-98	Homo sapiens	blood	B cell	not available	not applicable	not applicable	13	10	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_9	proteomic profiling by mass spectrometry	17Dec14_CLL_B_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_9.raw	108	1	not applicable	TMT129N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-98	Homo sapiens	blood	B cell	not available	not applicable	not applicable	14	11	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_9	proteomic profiling by mass spectrometry	17Dec14_CLL_B_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_9.raw	108	1	not applicable	TMT129C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-98	Homo sapiens	blood	B cell	not available	not applicable	not applicable	15	12	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_9	proteomic profiling by mass spectrometry	17Dec14_CLL_B_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_9.raw	108	1	not applicable	TMT130N	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-99	Homo sapiens	blood	B cell	not available	not applicable	not applicable	16	13	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_9	proteomic profiling by mass spectrometry	17Dec14_CLL_B_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_9.raw	108	1	not applicable	TMT130C	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	40 NCE	5 ppm	0.02 Da	B cell
PXD002004-Sample-99	Homo sapiens	blood	B cell	not available	not applicable	not applicable	17	14	not available	not available	male	not available	CCL	no depletion	not applicable	17Dec14_CLL_B_9	proteomic profiling by mass spectrometry	17Dec14_CLL_B_9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/01/PXD002004/17Dec14_CLL_B_9.raw	108	1	not applicable	TMT131	NT=Trypsin;AC=MS:1001251	NT=LTQ Orbitrap Velos Pro;AC=MS:1003096	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Methylthio;AC=UNIMOD:39;TA=C;MT=Fixed	NT=Tandem Mass Tag 10-plex;AC=NCIT:C161869;TA=K;MT=Fixed	AC=MS:1000422;NT=HCD	41 NCE	5 ppm	0.02 Da	B cell
